var title_f39_61_40912="Bilateral pneumothoraces CT";
var content_f39_61_40912=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan of posttraumatic bilateral pneumothoraces",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows large right and small left anterior pneumothoraces, bibasilar pulmonary contusions, and bilateral subcutaneous emphysema.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40912=[""].join("\n");
var outline_f39_61_40912=null;
var title_f39_61_40913="Zones of open globe injury";
var content_f39_61_40913=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Zones of open globe injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 347px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40913=[""].join("\n");
var outline_f39_61_40913=null;
var title_f39_61_40914="2-finger method PI";
var content_f39_61_40914=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F61268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F61268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Infant CPR: 2-finger method",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 540px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAIcAUADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCS2hEcWEx2/GrOxBuwBvPeo4AQpU9umPSpCcZHDgcc1oMgZBuLFflPFP2FgVXIYU4HC/Pn0p4zyTyO5oQDZAEi2nnA/OiMZUDIyO/4UNjKjO7/AD3oKhAxxgHp7UARqTtKsMEEjj0qZlKtkfNjj602EGTG7qo6nuKep/jJ6kHr2oGKMeXlRyTzjtTSpchuhGDj+lK2BKCRhcbsjtTyWUyjjA6E+9AD0I3AJ06YNI7KxdV67sgilcqse1TgnHIqNiQYz0z39aAHJlSGbgg9fWpP+unC9COv401s7HUqWIIORQMrIP4gPvCgBUHl/KTkA8EU+XvuwOxxQyJ5ajOTnPB6UpG+MFvmOdu2gCHlEwGIz0z1pJCpbI9NpanMAi5LBghyAetRSvlgVOM/3hwR6UmMaWwGyflBwGx1NS/wAhgVxnmo1GGQPnBPc0853IoA9NvrSAYU3KXYBqsQ5c4bAyMfQD0pUUIxRcH1HbPtSRNjeTx6d6ewhflOFdjuAOPeqcjl2cNjgjkdKthioGQM9Rnsaoz8Fkzhm5zUtjRGsnzbgN3zYIz0rThUrEAT1x1rHtWPmMCQQeR9a2LeNvkwcqc4x2NKI2Txrk8AkDp9KrqMMzDDL0BxyKvAF8442g5FV8BZG2d+o9DVsRGOJNhOFbgEUu8FgpHyjioyuJEAUkBuTUiId5XPzA5/+vSGJHH83mqevyj0qaNsE8Z55xQMCBy54B6+nvSx9AwAKMOaBCqgCkNgqwzj1plwpwcqNp796ehBj+RmBY7TjtTnDCM78DHCtnrTAqwuETIY7M8ZqyuZtpYYweRVfqr425HH+RU9p/ql8vB+vrSQ2PVQOSc84ptwd7DPYZI9ankX5Tt7jk+9UQwyp5DY702IltHwQpGXIOKmu0zF9OcDtVeDDSRt1PrV0KWTpnB/SkhM52NiAd3XoMU8H5cn7w5xUag5I9KXcGBxwR3qgBmG0Bu/tUhPQc5POfWq65Uc8jNWEXuenrQgBl+Zcj5icf8A16EGfMDYKkcZ7U3zN27PVRjrzQny8YJJweaAJVfMgx024HtSKCzEEHH93+tAxuPXzD7cU4hmVmPD9evSgBqkRhgvPccdfUVKpG4nPJHTFRAsgbIADcg06DIkMg4YjoaACT7oyCVLZ49KeUxHtcBmT5gtC4dwVPyHPXv7UoICKSMuBt47g0AIrFYSVIKggkelPPzTblGAeDnoajtVKhix3RnAzjvSwqWBVyWz69qAJciMqAB169sU0tgMQC2OeO9KgLHDEhsYxjg0xDuQBl27SQaTARx5gzFhiT8wPekjjDR7X9fu1k6prttZqYoH8+56f7OPesJtTvbpSJZiF9F4rGVaMXbc2jRlI7N2jR1Z3UIeASw61Xnu7WM7TMhAPJByQfauPjgXIJBb681ZQAcbR+VZfWX2NVh/M61Z4SEaKVTnkjcOaep/eKS2cjqK5Tyo5RhlFWkhdVHkSshHvkGmsR3Qnh+zN2WQhmC4I6HNZtzIWIaPBPTNCXxh2rdR9R/rB0/GmSyDho2Dg9SOlacykroycHF6luIxttIALd+2K2bUEsSMYPP4Viw4AycENx9a2rI4QEYLMdufStIshk7HbE2M4Y4yKgkQhSy4Y55PersSbUbJ+U5PNQSRYj+UncOTVtCKqcMDuOMfNR03SHG3t34pZGAYqenXOO1On5O0Y2EAfjUjGsSGLD5QRz6GhGLOAQNv8JqFiGUMe+RjNOQFjGCSAOMj3qbjsXIQF44PPU8VFIC8TZzhWwCas4yoUkcD8DVfZvchR8q5qmIr3GCrDY2Mjlat2SAgICeece1VQCB8mWdOuO4q1atvlPkgjIxmhAye4+6MdRxj09aokho/lOdx4zV2cFFGOCOWyOtQqPlYr8y9Qp4IpsRXTKK56MmBjHatGIiQBVz16juKz/mLbVPfnI6j0q7buPK/d9sA57UkBzqjMbFQcikQDODyOtKzE4x0xTdxAcdutUIkbDY2kYPalEhDbWAIAwahiwwGc+oFOmJdSV4yMcdqABFDSZVuD0qTriNhg4/Co4wBtwSBjtT0PmFQecZBpDJjgKoHBYYNNckHB+8R97sajeUA7GGVAz7g0rEMRknORgevqKLgTM24KMBhnBz/ACpRhBtJ9qjQje6tj2PrSo28/Nw4OQD3ouA8DYSP4aIcnzFzwR+IpAS7kPgEjHFCDaS2eOBkUATIxKhT6c474oHzSbWOF/hwetNEjKxJOOeQO9IwIdU2/KvUf1FAEzKSEbHK+/auW8W619lP2a1/1jfMzg9B2ro9Quo7SGWbK4iTP1rym8me6uZZpDl3Yk1z4ipZcqNqMLu7JIZNz7pGyxPetW3kjyBnB9xiqemRxAr5jKpPqa6GO0jaPd8rLXEjuSIFFSKBVa4kEDBF79KsWySMASpA9TRvsBZiAFWI5YkIDSKM+9RsgRRu6VFHcQiTaFUn6U27BY2BEsi4IBBrMvrOW2Pm2/zJ0eP1HtWlaIv3oxtJ6+hq26B15FUnbVCsnozLsXMixMowCc57iuis3BVSME7unpXMyI9ndDYMxu3A/un2robMsyAMcMOn+FdtKXMrnFUhyuxrhG2MR0x0qvPggEYLN0H0q1E+4bunYj1qCWLKhF4wOD/St3qYlKfqd33z2qs8oWQhyc4xjHWrM5KRg++CTVfy181mGSRxzWbKQiIxVWCrw3JParZjXyfkOdhy3tUUiGOBQnLMcEVOjAxleQR196EAu4kbeuT0Hp60jkYIUEbTjjrSwcnGMEAZx1zSMMZZsFuhNMRWlGZAFOGB6/41cscqoBX6nPSqbAb8KSAP4u1WbJ2UtuYHIy3HFC3GTTf6QuSeCcAe4qBWHlspU8ev8qmG1OEbC55J7VFK+0srDAJ5780yRhUEkhjz29KntdgjZMYPQkHrUKjBQZ25zwR1p8bEbtwKAEYJ70kBgrtKhs8jimyDDDb90jn2NJGy/eUZOMEUn8WckkjPNNgJGxBGAfXBqZnwu9uhHTFQZKnIyadvBK8kZB7UXACqlByV9O+KfkoFzzkdaYr9gM8dRS5JXn7uec9vepGSEbiCcEgdDSjGdoGcdM9cVDGVjwp5z056/Snq2TkfMPToRQgJoz1x+J6fjSjDJzwccVAGDcKRjPQ0O+AoHNFwJwTk7uWQZGO9AkDAFMccYPao3kI4X72Mg9qXd5igDbu7+1FwJwQcBuwIBzxTgzFN2cY4OKrLIDwOD3U+tOjk2PIpPPp2p3Cxi+NrlYtOitlYGSRssB6CuGK+YwAyR6CtbxJeLe6k7If3UY2j3xVfTog75PTPSuCtLmkdtGNkXNPsgYwfIj6d1BouJVsGJjiWNz8vy8A1ovcLbxYHb0rKuJGujhlG33rCT6G+pE16yavDA0LSoyBnlA4Htmuju9XntLrTILPT3ure4P72VRkJzj8PWqNjaRRQNuwHbpx0rY0jy44hDG5DAdqpJD17EniBIxGE3FC65BFYFppQ37iHb38w/wCNbGp2jSuHDM3uTmnWMRGAe1Gt9RXL+lwNEQBI5X+65z+tajrxmo7VOB61ZfpzVCMu/hE0Dr/EOQfQirWkOWt1mJwVHzZ/vVHMPmqto0hGqT2zZKvllH0rWhK0rGdeN43OstwJCG6BhzRMA0LJk7s5z0IpkH+sU5IC9vWpJ8tgjhjwa9A4DPumLLgD5xztPSoVTfGSADuHToDirc8I4HQ56mopFHl7Ojr0AqGhkUSl3GeNmQfenIwdAsRBbJ74qMSs6YI+dfXpT41XGYwN69cDrSAkjPl7QAdw6k9abJlpWwcknIXGOKRiWdgDsfqAealjzLuyvyLjqOc0wK8rEyiMKCO3tU1ovJ8pvl/mahvgBkRg7geD2qSw3LEBjGDnil1AmjyzGORcZ5war3BUyDOcEHp0zVvyxvZ/4z/DUDLvYbRjrmmxCWy74ghIzjo3arFv8xZZB+7PAz0JoVl2q2MqMbR3prgiPLNhQ3GB0poDk4yNu5R83QjPepDkrg9B61VQlcnoD71J52Rg5yPSkBLuG3IHSmO/TDde1NMwOMnHbJFMLFc7gCCeO+KQyVCVPP3c8mncFsocge9QGQbeFypGD7/jSLINygkL264zSuBO7ARK3GD+OKEl3RcjHvnFRR5XITIZTwOoIoG0ZAADehpXGWWfHT2xnpTTJ8yllPHpUMbgKy5xz064pp2jB3l/Ve9FwsTk7cmNWIHP4UjMAA0Xzxk8g9ahDHCneSuO5/Wmu7RndnPHXsaVwsWd4UEKxK8Y3dRUOo3iw2VxLgq6qQpPr0qLz8sO+cjisjxBLixC/MCX79xUylZFRjdnOSNyBnk9av2j+WgxWNvPmZ7VejlwnWuCb1PQjHQ0mcykZNMlnjsrc3E5J5wigZyarwPuOKthMptdQyHsRmpjo7sqxh/27qbSl4oUWPsrdfzp9rr+ow3QkuIwUznMfVf8a1zpVs5z9z2DYq/p2gwSMDgbR/ETk1tcdjY0nU01K3EijDD73HBrVhhAbIFFjYxwRhIUwP51oxxADpSsQx0Cc1MyZXmnwr3qRgKuxJlXC1S09UXxFCSeSrfnitK74rHkk8rVbV9udzhaUHaaHNXgzsEDKc5z1Iz6VNtyyluABx9aghPzhj/Dwasj55DtO5TXpJnmtFSb90QXG4knP0rPlJ8wcYU8DHY1p3S7WOeF6DNU1URrkjnOeaUhogWMmRyAQ6nknkUPtiOFJAYZBp+SLlSF+VuQPf3pt1gRtGxGSTtY9vWoAUrtCtuB3H71TXTARoBgE9Md6gtssoRT93nIqS5OEXBADcdOlNbAys/zsG6ZP3T3qyAFSM4CsBwg6jmqyAb8gcDirAUs+1uXHpSQFkFVgXAJ3NmoWwG3qcLnaMVPxsB7H5QPw700q3mAKRgcAEdaskTYysjkrhv0HtQwC+YFJK8lSaV8Z2gfKo/AGoH3fZzuz5pzigDjIpGAXzAMEVCT8/b86It4Rdx7cnFI2A2SQDnNZ3KsTBhs54NPV8Eq2CMcYqv8xboCDzxThuHU8UrgTAbBjjGMjb2pSyNglcg4OKrhtjZzyKeXbaPlyMdVpXHYlf5DlGKkHg9jRKxwCwG717Go0Luh2gbsc7u9RiRtmHUbfalcCcsGYEnGepFJuxkBgG6j3+lQ7uPlIP1pwLBhyBz6UXHYcJMorYAHpmmqVxtwSD0OaaBywKsARyKiLBOmB360rjsSOUzjOMc8GsLxDLmNUGcA5yT1rXJDoVLbcdKwdU/eu6k5YDIrGpK1kbUo3bZir1qbJGMVApwanXBArnkdiWhZtXIYVt2WJG+asKH5WFbFhKFIqFuFjobW2iYDKKfwrUgsYAOECn1HFZlnMCBg1rQTDjmtFYTL9uoRQKsAiqSyg96kEhq7k2LyPih3yKqLKaeWyKLhYiuDuOKoyxZurZjztccVakbDU+2jEpyxxjkfWknZ3KaurGpCGLEjHPbpmr9oo/4EBzVK0DsWjfAB5BrUt1PljHGOD716UHdXPMmrOxWvEG1S33e9ZsjAK2ORjj1rYusbdqg4xz71ilDvKjIGeDTkJDYyfMIC4yPyqBotzcDOeq+9XolTkKcjv9aqkvGI9ykjJU4qOgx0GGxHkYXgbe1WJRwAflbPP0qG3Cq+5B8hGakkz5wKkY96a2EyvmNSxxzuwOaUblZgDkgdaeUBbdkBM5yR3qNz+6YOCM9D3NL1AsWx8yEmTCqTzj1qXB4AGR0BPpUNllUCMu3J+uRVuP5JGUnIHA9qpbCZWnHzGNWI9x/WopDkgFSR/d/rUkg2mQjOc/NUBXlC5xt5PakwRxBPync2R+tMyFPzN+VLnMeCASO470gJb7pFZ3KHq2RyCCO9KCMAMQc9+9MABxtf26dKV23LkgZBwcUXAerBSRgNkVGrsGPy9R27UM3fhh+opp5bcpIUetSxolLuCGVfxzSK7EkgjHPT1oj8s8FRuBznOKRdmSCOeoyaBjg3OSp9DikGX+6+CPWmhgrA5K57dqc5ZDnbketIYimTHLAEHjNIzNkZVeeOBTmOcbozjsag81gOex6GgEBc8Bx+Nc9fs6X7kAMhjJzW2ZCpJUhlHqOlVphEcMwO3GcdcmsqiujalLlZz9zFtIYD5WGahRsGtafEkB4xtOMVkTLtesWu51Ra6FuJw3fmrluSCMVkwtyK1bNskCsmtTQ2bJpRjAratvNOM1l2gxit6ywccVaSJZYgilI5NXY4XxT7dc1cjx0xWiSIuVliIp7DaKsECq9ycLQ1Ya1KczDfz0q5CM24I+6cYrEv5jHFK3oK0La/T+yUMbAuQFUVEdXYctFc3NPZDOjISUf1NbCjrwevWsXTlKpGeMMc4xW3DghQT8x/WvUp7HmVNyte9cD5QB2rL3ckcccFT0HvWreY25I3SZxgelZLcSlCTu6j605kogICEgcKORipTIDGAQDnoBTmRgN5OSTyuO1QupXIUl1PI9VNRsUEZw2G+6OpFOflQQxxngGmoVQNt53df/r0RhiSGG8r+lCEShiMq3DFeB1qusTvMRKRgDoKldtxUg/Op/Sk2+Y5LLx2OetMCaM+SEc9GHA6mpkIefA6EdqgdwUwSM5wD/dp1qpaQkZJ+uAKa8iRZVw7LjGefwquPvkYxxw3tVwDYxZhvBPJPrVcIZJ9pOQBkjsKbA86RDHtRyCcdfWnEFHJ4C/nT5IyGCuhVx1B601hwOv0zWJQvQgkce3WlBRSeOCeQaFUBSNxz9aUqGXb/OkMezAEBk5PtgUwOCTxgj9KTcApBPH6Cggbf4c49aQ0OKqQ2fqCRTW2gLkk+9OZCANhJXHc9KjYFFJB6c0mAqcq2RuANKrgDkscU1XXdlSAT1GKtQ2804LRKC35UDKruoGVbIPY1EzA5woB64NXJ7SdQRJC49wMiqEwUHD5HSkNETlXXBG09fY1SkbaOgq6wG7cTlccYqjMRlhjr61LLRVdsuQejcH69qpXcZAz3FXJRuX3qGT5otx+hrOS6nRSfQz4+CK1rIjg1movz47Vo2owRWEjpOhsnyBW/Ydq5vTiMgV0tpwARVIhm1D0q0g4FUYH4q6jcCtEQx7Diqd5wKuOeKo3ZzSY0c5rzEW4UHBkYD8OtT6CoVwCBtIx+NVfEB/f2qf7x/lVvRrdd28MSg9+fwq6aM6r1OvsmDEHGAcAY7VtxLkDB75zWDpgbaRIdrLnaDW1aNgBTnee1d0DhmMvtp27jwemOxrHmByxI+YHGa2rsLkBuQc/5+tZM4fzAGGcDP19KcxRGsCVG7Abjp35pjqwchAMjnn1pFZWk4G31FPfLPxhn7E8YFQMZFEN25gDngDtn3pSwTerHbJiiTKyqFzsBwc0/Zu+ZCcd88kimhESEBflAZe4zzS3DLGArZB6KPSm4GeByTnntSKjSEu2WJOVBPegBjZEiqSNo7VdVsFAVwrjHX0qq53RqQnz8gg1btsNACxz3z1xihCY92+fY+DFt/I1Wj3KflbG7JKmn3EgG2QEEEY47mq8jklC3AzndTbFYzXh/tHavlgnuSOn41larpTWRRk+dWzn2NdFDILePAGGbmkvRHJDGkn8YJz71hzdC+U40FeQV4PtTSpSVivA/StaawYzFAdr9AezVGLXGqTQsB5YUIv1xmi47GaQCcDgHrioZJVhwS4GOnGc1ej08tNqUDsSBGGU/wB01HFEJ9NjmwBIvyt70rjsZ7XE78pGyr69aVGZz8/IP4VeghyDt+Ud6DEpyQOPWlYZXVAvKZFTJcyQnKMc0oUAe1RsvNIaLq6xOB84V8eopp1ET8SW8bD3qmIS1W7WBQwoVykWE0mC9jJjjMTf7JrI1XQLm2VpIz5sa8sMYYD1967DTvkO0dcZrQZ1dfmAPFVa+4r2PIGOQCcEmoCM7l9ea9PvvD+n3oLNAqt/ej+U1y2qeE7i3fzbFjPGOqH74/xqXB20NIT1ucjtw3FaNqu4Cq7RFJyjqQQeQRgitC0QDHvXJJHcmW7fKkYrbs5XIAzWbFDnFalqu0ihCZr2R/vGtNDkDFZMJIGBWjAcAZq0yGi0eRVWdeam3VHIwNNgjlfECg6jandj922Pzq/pwYBgo3YI4xVTxLGQ1tOBkI5U/j/+qrWlznAJwQO/c1rTehjU3OlsJM5YkEt0Hofety2PCEDleCe+K5pGKkKo+fjHFbtk5CL6ZxXVB2OSaL1wqhG7r1Prmsa8VjIGx0GOO1bhUPFjocZ471lX+1GBbqwP41rJXRmiknyMA2Xc5PpimOTlWcHPp6004Yll5IwpHpUlwo2fMST0HrWW5QhyOEJxyMAUKfmUj5Sf4femu5RlaTA5xxSrwwdmwSeM88UASOAJMAgkDIB7moHyJNwOE64/u1KmQec4ByKWZF3synjIIUjP5U9xDNwSF2YrvAypA6io1mcvtQDa4yecYpNrJK2MMpGAOtKAVQouZEPOfSkArJvYNkEMMD1BqyluGgUbuSdvIqvAqRxKVJBOSfer8Tcgvt5XjFOPmJmHef8AIQSNei8Crt9AWskwPnUZFVrRPtGpGQDgcfU1pajIEyAOFGBXOktWzTqrGZAguFQj769/UVna0TFfMy8bXRyfwYf0FaVirRXChhgPyPb2qDXIvMsbmQ/eT5c+wORSexS3K86CJL65AzvQYrH0+JmtDCOrNk+1b7fPo8KAfNKoJqhpEXlxGQjoTVW1F0IXhy4hThE5dvWq6RfaHKodsK/eb09qsXjPs8uL/WSnFSzQrDFHaKcIo3SH1o8xIz2AcllGIhwo/vGlkhKAAj5j+lXrSMTN9oYbYI+EHr71Vd/OumOflXk0mNDAu1ealslLSdOKVVLCIY5c1etogjnjjNOxSLkQ8uWB+2dp/GpslU56IxU/Sh1/0c+2DUzIHaQA/eANMLFKKdkJVjh432H+hq7FPFMwBIR+47fWs+4h/fBs48xQp+o6GpFhIYk9jSVwsP1HRrS+B+0QI5/vrww/GuduvC0tqDJaM00Y/gI+Yf411EcfcZBPcHFTJ5inhz+PNEkpbo0hOUdjibZCGIYYI6g1oxR4wQK6S90uK6HmEBJT/EO/1rFmhls5NkyZHYjoa5p03HXodMKimLF16VdjJIHas/zxj5VwaY0kjHg4qL2LsbHGOoqvLMinG6qcQI5Zifxp4QE80NhYS6jjuomjY/Kw/KsuLzrBiJlYJ0DAcfnW3HFVgQZWqjKxMo8xT0+581x82QD1zXRWkolkAQ/Iefp7Cufl0+MncgKP6rxVyxupIGVZjnB4fp+Yrop1VszmqUXujrozhCV5x3qhexmRmH3geQPSrUMmYcpgqT2pko+XKg4/mK7ehx7MwrhSs6hCQDz0ouN+4MRgrzgHGamuQpzvJyW49qiUGNlctuQjkE96yZaEAGwyghgemTwf/r1KXxsk2rg8bfSo2OdyMmUJyntTEI8s9lHGKQh4JbcQcH+EZq3Gu6FSAPMIweelQRgJuLgug4GDyKfuKMvGVHBPtVLQTICgQ4fKlu56VDHNibIXau3HJ4qWTJchzwR3qrGxchWDY5XPrUsaL8URILAcc5DDOKtpGFiO0AE+9VIXWIFNw3DHFaEJLIwQKSeRiriSyjYw+SCQPujNRxqZ2zN94dR2NX5sRw4yMscCq0S7cnvmsIIvchUBrgZ9eKr62u3Rrzjk5H+fzq5Go80nHAPFQ+IRmzSIfemlUY9s0NFLcqOgit4lP8MfH5VAtvshij7BctVu/G66VAOMYqtesXmEUfU8H6UmBBbQqJJLplyqfLGPU1WaCW5uFh5DynLn0WtC7mWCFIxgle3vTrFfItpLiU/vHHU+lAeZn6hIBF5MA2wpxn1qlBbMIB/flbFWyGmYZ4jB/Or1oA99uIHlwLmha7htsRQ24/tBY+0Q/pVkRgUungmOe4brI2BTjx2pjJMbo2HtQxKfZ5M8Mu0/UU1eh5qUgHTskfckGPxoAa4ViBjODkUt9IsV2OflcBqkhwcYxUer6dLe2atbYFzCcqCcBlPUUmn0Kja+pPEFdcgjFTxQjcO4rhZ9euNJkEWoW08B7ZXII9iODW7pGvx3SqyH5T71n7XWzNvYtK6OslVUjUDp3qrcWsdzCySAFT0Pp705JlmjB70FmQgdVPBrW90ZWszj723e0uGjk/A+opsZzW54qCG0t2AxIHwPpisGIEVxzXK7HbTlzRuTjI6U1LiPzQjOA/pUi9KjSxikuBId2cgkA8EioKNSFcjmpuhpY1OzpTD1xVWsIkIyOahljBFSbu1HUUAP0u+ayco+WhbqP7vuK2mkDtvgYMnUe9c4y8mrFhdfZXwwLRntnofWumjWcfdlsc1aipe9Hcs6ghABUEgnkelQORIAjA78jn296fcOWYlWIwuc44NQRB5HUA5ORkd66G7s5Ei08e7bg5wabKQVxIoxgYHv61McB13jknoP0qNnAn/edDxkdjVbCIyhjVupBXOKdEd4ZRuwRnntUh+6SvLqOg7+9KiK8StGeoz16miwitKdiYI3DvjqDVKJsyHqrD7vPSrs3zqM8r/FjqTVEErPsDY45z1AzUyGi1bNuLb2GR/nFbGnE+S4ICHOASKxYX2k7hks2V+XOK1LaQuTvOWxzxx+dOGjFIiuJllkIH3U4FIGHbFZaTEHDDBqzHKDjJx71kmapF6P7wGBiqt/+91G2H8K5NTxvtRnJz2FU3b/AImEQH8KE0mwElINxI56Cqy/Irzn77nCVLNkggdWNR3ALyxxr0AxSCxVjj3ymWTlF6e5qbUnPlxQDqeTT8q0saAYjQ/ypqAPJJcPzzhaPILFZwFb2QD86ltgU0+QjO6ZtoqJ13B/qa0LWLP2RD91VMh/z+FLcdidk8tYoR0Uc/Wq85w6jtUkjEzMR61XnbfcRRryc1VxWLSIOKkmUDT5gOxB/WmTAxt9KliZHVkbo42mhgiGzbcBWtbEYx61zu27si3mxAxA/fQ549T6VpWF0ko6ikp23LcOqF8W6bBd+Hb0TqCEiaRD3VgMgivK/C8rW9yyZ+Rzkexr0TxxrKWujSWiMGnuVKAei9zXnVvFiPjg9jXPVmubQ68PB8juek6XcFkArfjAZMHqRXmuh675DCK8IB6CTsfr713dlqELR7zIoXHUnpWsKiaMatNo5vV555NQeC4wPIOAB0PvUQzRe3CXmqXU6H92W2qfUDvSI3ze1csndnTFWiizEDViMYIqOMjFTpzQhmlBjy6hcfPToThRSS+taN3RKK11MIdpPQnFNW5Vhwaqa6SLCQjqvzflWBp2o9dxzuOazbszRRujqfNBNSfeFZMNwGNXo5Rxg007ktWLCswHl5wpq5Z7ViCMBxzmqfDLVmy5LBsnI557e1dVGf2Wclan9pFp1PzBMEAcMe1VTw4T5twOR6E+9XdhWMt1A457VWWPbtJ5B6giupnKhYA0qkPgArgHGKfFKIfkjAZwME9sU0SfIXyCem0HinMfkUk4Ynj6UCCfOFVW+bPy+marPEFALgM5+8V71NnKttxgHAz1zTGzJF8wO0c9+v50nqIhhjePDkl8NnaDyBV+OTADIrFcDK5zmq8K7ZUJO1CMfU1ZldUIOV3AfNzjI+nrQtBs5Aai2AT8wzg56ipodTTIHPPSsrYZBjAKnuD0qIK0RHBZPUdqzsUpM6j+0Y3SPa4xgnr3pVl/0lpM5ygArlppBtLAkqT8xI5BpqTSoB5MzE44Ht7VDVikzrhMrOOegNEbjJbPO3Arlor64DrhlbcOM/41ZXVtnDLuPYIc/hSHobwTkKvdcE04qCFUcIDisaPWoh99ZFPoVpi+JdOzg3ABB7g0XtuNK+xsmLlh61fVSkMRHXy9v61z8Ov6dIeLyHPu2P51qpqtpLagx3MLeXndiQcD1pcyHyS7EpRgCRyTUdghW/Msi5CqTVdNa048/bbbH/XVf8aW31zS2neI39t5jLgASA4+p7UnND5Zdi8ys7kseSakSLFUIta095Si3cG7OMFx1rQgnjkG6ORW9wQapSQuVo07RAYjv546GuL8VrLoUiXdlHvhlbDKxOEb/A12UcuFxkfhXMePplGkrD/FLIuB9Oc0qjXIy6Xx2ODuLifULtri6bdI3p0A9BVy3j46VBbx9KuphOAMt2ArhPQ20QPBCBmRRk9qsW1tb7AY14PbNLBAd2+Tlv5VIYHDloW2buoxTEOM0cbbMHA4yOgq1GM4IINJb2yrGUxnPXPeo/KltGzGC8PcdxTFoy/HVyGqMEySgFDn2q5EaZJcRsCpOCOagQ1MtMRT1ODzbeRP7ykV5Np18ySGKQ/PGxU/ga9inGUNeFaoDDr16VyMTtwPrTceZFwlyne2d5uQHNa9ncZ71w2mXWVAzXQWdxjHNYp2NZROwhkBA5qxE5R1deoNYNrdAgDNadrMC2DWqkc8om/JLkBgf3bDoO1ROwbCqQO3FQ2jgNt3HaenPenXOVYEJ8w4LAdvWvRhPnjc86cOWVgR1GFcbTnqe9EivyDhscjAptuF3S7jnPHNWJWVo/m6nofWrWpmypbkEqxIKk9MjNTTIAp2MYlAzz/Koymw7QoDY7cA1ciUNEwbI7c8/lSXYGV9u1IWReoyf8KjkfJO5cL6gY2/jTpss5iwAAMlccilK4i8tW4brk0COBR1jOWEgU9T/hSjajlEZ2RunHSkXKgnjIPOT1/wp8gbjaGxgEEn/PFZlEas4DKGBXB4PWoZFkBHl8gfMueMGpnMgUM0cYUjr6GmmWWWHaWQlT0HWpYyKL525QMM8hTwamjn8sEHaozgNxlfr7VFGG3lmCkdTzj8abdkQQSTFQQBj5sZJ7Um7K47X0M/XdTZiIY8b8YYgYrNgh+XJqOFGnnLtzk5rUEW1cVyyberO6nBRVjDvk2ZOKypXBPAFdBqKDafauZmyJTioWp0rRD0TewCjk101tZ/ZLdV2rucEljjr6VU0uyEUHnTZV2Hygr0960441YBcqVx/EcYrphGyOWtU5nZGTcIHuFXJO0dD2q9p1xPYyb7aQoe47H8KrFNty4Pbjipl61yzlqbxSsjsNL8XXEfFzAsnoVbBqtf3s+qXHnXBHAwqjoorFtxyK0oiAKXM3oxqCTukSxxkkAVehjCduaigxVtF4zSG2SoBiplFNjwBUgIq0iSaMYqSoo2x9KkyKYiPyE37l+VvarEeR15qNSM1MopgTwnOKtKOKqxKRirqDinYkinHyGvE/EEePEN+B/z2bivbpvumvHdcXd4hvz28404gytbRlF3J1A5Fa9pccAiobBAHDHFWb20MP8ApEIzC33gP4TWdSm2uZGtOp9lmhDdhQMHmrkd+7EBTiuetiW5rQtzhxWCky5ROz0yZmC7jzWtIwRSw5z/AA1z+mPlRXQKFeHBzwMiuyhOzscVaHMrj4VLv3AC8EetBO+Nm3Yf07YoLLDGEQ4HXkcioZC27bG2ABnPY13nCx6Lgl2XjPGOavI2zcHxk+n+FQsqxhSw3K3oOPxp/wAxiLhmPt3FNCY2bbkEYLAYJAqOSMybEUfK3JOOlM/jLIwww4+v0qRCyIUUHPUtSuI85ViAVY8553Dg1P5MQVQFkAxjg5xVSVm6HbgjIY5zUsExVioYk9QxHQ+mKxRY6PcJHRzlGwcEdKhuY3DsyBSPUGrbr5xDlxuxjAHQ+mabJBtkwzEq4wfQH3oaGik29l8wPhxww71matd+fKkC8Yxu9CfpV+6jNshcA9xx0rFt8Ndb5O5rCpK3um9KN3c0bK2CgcVakj4NWLQxuoCmpbmNVWsmdaOX1X5UbNYun2huLosVzGnLHHH41t6mhll2Lzk9Kt6faraxAFWDHqwPB9qqlG7uKrU5Y2W5NOjOoMbkoB/F0FZ0siCTdIr7x6HIBrWuEOczfMp6betQwwRGcP5e32JzW7OSLMCeYfamKjarc4qeJ8118K2zgiWCJwRg5UdKbLoOn3LDyC1s2P4eV/KsZUObVM3jiEtGjn4X6Vdjkzip38O3se5ojHMg6bWwT+BqIWV3EQHt5QT/ALNYOnOO6N1Ug9mX7eQAVfikB61jIxXhgQfQjFWIp+goK3NpSNuaiWdWJ2nNMiWeSMGOGR1JxkCrVn4fvHYOsLKrHPzNwK0UJPZGbnGO7HwtxUwOauQ6BdDdvdQR6c5qwPD93kbXRh39q09jPsZ+3p9zPjHNWVwOtWW0O9jUnCNjsD1qCW1u4mK/ZpGI/ujNDpTW6GqsHsyaEZxVtRhah0+xu5MGYLAp6A8mtuDTLcD95Mzn64rWNCTMpYiEWYk54NeRagRNqd246GVv5177Np+nvHsb5cjqGrzTxH4CuraWSfSGN3bDL7f41/xpvDSS01EsRGXkctaJjnoK3NOkXLRyDKSDBz6VkQoykqwIYcEEYIrW075ZcvjC/nUQ0ZcndGNCu0svoSKuQffFMuo/Kvp16DdkfQ80+PgiuCUeWTR23vG50+ldAK6S17CuX0l+BXUWnODW9M5pCuxjfCHKkemafFkxgSAMDwNh61HOgWRmjfLckqen51NbR4jV3Hrle4/wr0Y6nnyVh0gPlbdvJ6L047c1NEmzO7JcLgZ4/KlCAMWHcc570tucEF+R1IwSOa0MyrFGXccKHBOM9cUkKruYH7w6sDn8Ks3eVk3qBlztGRjFIiAsDhdw/iXtik1qFzzPC4CsrKR91j/WnMGD7j3GPl/mKdFIro4bcV4BHXBpQzCPJG9F4yO3tWBYNGwclXykn3lNMADAAFQPfv8Aj2qQO0KnGxgCCD1prSqZCY1+UnkY6GgaKGptiz2q4I3cqDn8aj0WwEi+bIPcVYnt/NuQrAYAzgetT2oeF/L6JXJUl7x20Y+6Z2oXZhuRHAAMdavIWuLTfHk46isDVIpV1tE5ZZOldtolmILQLJySMms43e5s9DmEhC7pJY2JPTjpV2NGLALFuQnIGakuRJHOB5hZHHX2pjIUBdN7Jndg9R+HpXbFW0OCUnJ3Zt2Gi20lvG2CT1IPY1PJoMJGdoUeoNZEN7Pbt5sThxkAgjAH1rdiupr62XCFGboc1ejM3cpjRYx/y0ZfyqwmnwR4PmbiPU1G2nX7YJcAZ/EVZh0ibcu5yy9+2KST7CbXcnhhtxwOuMDmnyW2MNFKQfRqt2mkEZyTWnbaQNuJDz1zWii2S5JHKSRXDyhfKWQnpgZrd0Tw60yiW7iVTnhSo/Ot6CztYiCdu72q+LqKNflGB61caSWrJc3sivDYRW9uFRF45IxxTjECwK9+g7CiS7jbb8xx7UrXSjgCtCRfIBY/yqQJy3ZT1qqt2W3cDg44pBcO2cGgC4EB9h6nvUnlRjjGM1QdpP7xAAqBZJC3L4ycU9QNgRRErkA4o8uIE/dyevFY9zcSwRkqCfrV7SZhKAZzlvpT62YrFiOCIuSYlwOh65p7bUGAuF+lW2IU/IBgjtVeTJB3VdrCueffEnSYQsWpQqFkz5cuB970NcfaRHIOFx9a9a1aC0uYfLuVV0BztauK1TTrdLxPso2A8bQeK5a0Ly5jqpVNLM5bW4h9qjlUYVkA/EVSUV1WvWq/2WhBBk39D1rnhEYmG8da87EQtI9CjO8DX0WNjjINddZqVUZrmdIlXIGea6q1OVApU0KRNFCk8rb1Dhex4qZ4cybslB0xxgD0qw0f7gFc57ckGoZ5SqnJxyAw6j8K9SKsjzZO7K6SslwoZAu31IxUqlYyx5OD3zwfaq8xySSoMROQCe1SoFdR5TEDP3QOn+IoJY0EtOQ249wc5pNyI7x5xzkEcY/GnySDcAgGTwzj0qvMCZVaTbsXkg8ZoYHnEke5meJSFI+bB/WlgkbLrkNnqCT83rQrAMRwVxwB3pMDc2ODngY5rmNBVMaBtvAB4Uc/pT3OctHja3UHp9RTJVQgyBfm2564zTNgkAYZ9wDQMnhVmJcj5h696Qygy7JQFyeCOlLbZQMqtk9eetWLdFkf9+mPU9jXFUT5md1J3iieLSorkRvIQGQ7lPof8Kt3MptbVgQikjGQ2c/SmSSwxJ8juOOgOaybo/aJT8zLgYGefxNXCN9gqT5URCYSKoTJweCeo/CmqG3Eq2yT2NIY04KnJHylf8DT2WRJcblDEZz/AHq6jiEeKVvlYhc/r/Q11fhu4AtyhwWj4Ax1Fc9GZDAPM7mrenTPA5eLAPQ1SdmJq6Ote4kVuIUYeqmkXUGUj9yBUdhcxuwYcj+JT2rS1C0UW6yoPlPpW0VdXMXpoVG1WXHyBVNON2zsMsx5wajht0YAADJ5xVmGIL8pGST19KpJiuTq7eUODmnOzFNpxtPBIp0hAiUtjrimKcHkYye3aqEMYsqqDyAc5FOaYI44+XGM4pkrZjKr1zwar+aMFGyVz19DUtjRrqYzHviAJYc02PZt3ZIJ6D0qlbNuGBgAjBINN87y2Cgnr1Peq5gsXrrftA3Z96jiyjhScN14qrLdKBlT15+tJ55eRcDr09qTkFja3RyxlZQCCMVBHE1v8yHKjoe9VLZmkzzntV6ElUAOeBzVc1xbGlaznaobuM0tzIMFV61SAZyNo2irEcW7DEmqTYjnNY8wZJztrBciSN5JcKq9DzzXX+JkC2QIGXLYHrXOPp0k+mNGuzzCcj/CsZxdzem11MRAs6vd3OFjX7g7AVgX92s8mIPuA9a7a38NmeNP7Qc+QvAhQ4z9TWL4m0uy01YxayDzM4MfGQK4Z0JuPPI74VYX5YlTw+A0nXkGu0iUoARXI+Grd/PDMCFPSuzQ/LtrGmi5Gi8gNrvDhCRjms0SJNKRkAocEeg9c0skrRptx8nU96iVv3bkrwT/AAjJH4V6UZc0UebKPK2iWRWeTYpCgDIUL1/wpI52woKY29MnoaZCp3Kckrj5ZAOTUzowL7RkHqT1/lTJGPHuO5eMcsR1JpsygoWYMcD7hHb1qUMPJwxO1hgZB4+tV3O4KWKYAx06UxHnrRqVUOAoI4ZT1+tIyqw4Kbxxkcbh/jT3jYfOC3UEj+tPRgql+HG7oRXMaECu7BgwXju2MVGWAfK4OPbjFTyfP87DAHGwckU2aL5g2Rg9R1xSGhgYxOC42jHQc/rWraSyoMKC6kZ64NZxjAQxrkOBnp1p5LhPMiOCoAIB5/Gs50+bVGtOpy6MdqEsjsVwFHpmq6oxfgD7vU9RTgkk6bt+cdRjmmeVKFIUFiOfTFOEOVBUnzsUP5edy5DHnjqKn28BlyW7Er+lRAl8KpBYjBHI/L3pwc7SOSR1DHitDIuuo8mMrwCOlLAMdMipjAotEGSWApLXO8Lk5+tJ7hfQtWMjpcLz1616Baqt1pZTP8P61ylhYojeYWDMa6bTJVXKnkniumjpozGeplMRC2R98dvSpjIPLRhy3OMdak1a1Kzh1+62BxVJ/ljCMMMD1p3aDdFl3DxgEdT0IpUJLYzx1PPFQQyFn5PIHX1qac/u28vO1ecmrWpLI5HGWTHzA5B9qoTuVZgpyCDxTfMYuXzkEc5qnM588kHOKykykaVtchGQZ+XHPvSNMZHOB16VTQk7RyGJ4yK07W1IALY56gUldgJbxM4K4zt9at28XzHcBjHGfWp7a3xI6kj5jn9KllCx7Mgcdc8AmtFElsjRdhjA4G7itCCMk8k4JqhGfNldepUggg9a1oUKgcnLHNWkImjjAIbP0qwq7VpvCdec/pShwwIPFaJCOQ168aa/2/dWPhQe9O07AjG8Dd6VPr1iDKJVUZPWmWS/6OjAnIPA9Kza9416FsLiNivpjHoa4DUNPaO7k+0n96Tk7jnNejIAq/73PTvXO+KdGe9nWeCMsQuGANZYiHNDQ2w81GVmYNrcJDiOIhpTwMcha3XuPJEEY5kkGa56C2SzkPmgqw7Y5q/aTGW8+1XHyIg2qD2FeZqj0dHsas8jLJGpOAepxmpIkYSsy8h+gHQj8KTHmpHJg5POR/D6VNArjaCAQTjGBx78130tYo86rpJjkj2ABcnn360ryImRlSCcMvFSjbErhcAvzgfzqlgoqtLtZR6defetdjHcHGwOmDgnI75qNnIUrgbCnpxT9rkYxhQDjP8AWoPl8vbGSD1JUcUgOJieRCTxjHIP+NK0ZGHBG/PTHBFRhwkm1SPm6HGfzp4ZyuzK57+ornLEuUcKSpf6dvzqEh84YbehxnNWVGfMUvyeq+vuKheMxIGUDjsf8KBoSUSpKH5aM85zwM9qUsnmuFZ1J5wR0P1qSNy+QFIHb29RSNbsW3YVwOgNAEeGMgYYyO+ODR5/K4yCOxHShoSrnJ2Z5IAp8OCCF5JGCpGBQMhYsMEdO68fpUqTNMil85HcjmlitU3ZU4/Doa0rGyUReZcbVXPGKEmJtFfzHdAAOBREHDBgpzWkfsmeN4I7gVbs4oMj94uQcihR1FzDYJp9gI6jvmtrSr3zMBziQdvWoRCiD5dpH0qnIghmDJuBzkVorxI3O0nUT2nTBrmbgMZhg9PvA963NJuRNb4boRwPWqV7CUm9BW8tVchaGUmROhViOeVxVueT907gAAnkZqo0JBGTyG49QanjDndGRuDc9OKzTsUUZSWkYoRnaTgdCaiht3lcP90dgPWtaK12llRCCepY5xV21tcYBC/TtQo3FcoW1owcEDdzkj+7Wq0AjAAI5G4CrSReWuWx14qrdzhTkMRt44960sooncWAhBwDkd8fyqlfTHzQqnpwT3qKa6WOMhNxyO9JpFsbmYyMwOOQOtTzX0Rdupr6Vbg7WYHGMA1oGVI2HzZJ7CqNxeLAnkQDLYwcVXitp5wHYnHuK1UraIixovdDOQwyOatRSbhngnNZyWwj2B8A9SParMMQQMysMdgDmndjLM0KyoQwrEjj2O0f904HvW4u8dRx61m3URS9DAcNQxolhUgDccn+lMclIum7JzUiKee47g0ybPHIwOMdqYGNqCxurb0DHnj0+hrHh01ZcMZCDjIU81rXKZc8nbtIPoPzqK1ZgdzAnP8AEOrfl0rnqQUnqjaE5R2ZYtVCQICcDPJU5qZQQuHCqDk5B5pBvVSUHyjk9SaiuZGLkg/KACVGP500lFWRDbk7sHmxGdo3EdQByaqqUJ/eAFWGVGO9OmfBAhwQRksDyP0qCYGPYhwT1zSbAfK5Z/mH7vsxPK/4VAwwAQcOeGCg4NOJIik8wDJHDY4/CrFpHKgOdpJI28dsc/jS3EcO67sgx53DjHGCKidkBR8LjGDk4NBjBQrkgjkHqPxpyn5QGKb16b+h/GsCxASxwyhv7r/40xZcZVgcjrn3oZmTO1xjg4ByD60fMwG1cnGM96BiIX+YgE/7JyBTpVRCHRsbuepx9KRCzMwLKPZuM0i4BIUkZ4xnPNIB8cpdcDjjsc0xB+8UwsVYk9elMYqxyNxYdQacSMAll2emDQM0LCN3ut0uAijLEAc1YuJDKxIGFHQDtS2YzagIgDOdvHGRRd3dpp3yOnnTdwDwKptJaiinJ2RHEpLc5q/BDuOCAfTNY6+I7YPg2Py+qvz/ACrY0/VdNuWVVm8mQ9BKNv69KUJxfUc6U0r2L8SSxANE5AAzg8jFR3F0rvsuU2SHjIPBrUjjBAJAK4yMenYVBqOniaE4AJH8+9buOmhjcuaGQqKgyRWjessjLhc7a5rwzO0dy9tLkrjcueo9q35my2ATk96cX7oNaldwreYAikg9TUaP2Dcd/SrToduAMk9TUENsd+4jKjk0NCJ4ySMxgt9avW6kqGAAx1AHSmW8WF+Xj0qwflTA7VcV1EyvezbE64NYlw24E9ffNXLuUySY7VRmLBfkZSO4xWcpXLSKjoZWAUbq6DTk8q1JiX5yMcVQsLRpyQy45GD0rUur9LQNFCAZAPmJ6CnTVtRPXQdDZJETNcH5+vvRcX7FtkZ2JnGPXish7uSdxyWO7H4EUBJAFeTCD5eXOP51fMlsKxejuGYqWOCdv860bViMfnWALq0hADXSMw/uZbHNaFpqdoWVRKVJ/vKQPzpKor7lezla9joYgDnPU9aq3oCqDwRmp7eRJFDI6sp6FTkUt4m+3OOo54rbcz2KkCllYngnpmoJUEa8Z255zVmFcoST1qtd8ja65GeDjPWjoUYt2QrMi/KzfeHTH6VFFjhmHHTrjJ/xqa4TcY8jcCcc4NRgjcqHaO+3jg1i9y0WFbZjkoPXA4qKXc4YrkZ6bed314phZ0ZlUk91xUanzZuhC9cDjn1waTYiuXGTuTBHXnAzSyJtlUFc7l3Eg8j6GrToNrbMYGD909ff0qEcZ3ELt5+b+lS0O5KqqsG113qWDKcjrSByojZCPmztQkkimKQAGb5dxyM88+nAqd92fmYngHhTxTEcBFJnuR1IY9vwqZB+8IYIcjv2PaofuyGQBSp7gkfnTQoaU4YBPQnkfSucsfIo2hl2kdGwMVC8SI+VyQRnhsCpiCM8A8ZzkfN3pFkQlhnGTkZ4x70MZCrqQBIzFe2M0jDEoZA+Ohz0NPYOhzgAj0qN8Od2NuD04pAh7bOijKnkAnP/ANenEghlY5OMjBx+dRvjadpUg89RwaRZnLBgnJ4PI5oA6Et9k09ZeMxx5H1J4rjrpy7ksSSTz711fiKQpp0YxjdtH6ZrjpTyaxrvWx0YZaXGr1rQtUDdRxVCPqK1LNeRXMjrNfTJ7mxbdaSlVPJjb5kP4f4V1umaxBdBYrkC3nbjDH5WPsf6VyUA6VpwRLIm11yD2rqpVpQMalGM99zZ1eza3mS8gHKnJHtV2KZbhUcZIYZqlp928ey0vHM0Uh2pI3LA9lb/ABp1rGbS5e2Y/J99Pp6V2JqWqOCUHF2ZqohJHJA6fWrIQEgqPqKpi4HASr0DELnqatNGbRLGu0YNQ3TYU4qQtheelULmXLbR3pydkJIq8jcWU/Wokj8yUHBAPepX3YxTUdYVLHpWRZcuJfIgEcB/etwPb3rmdS1W0syfOkMsveNTz75PaoNf1hljMUTESOPmb+6PSuLuHLMcmsq2I5dInVRw99ZG/J4lupTsgxBHxwnX8+tQG4kl5kZmOO5zWRbda0E7VxupKW7OuMFHZGlaMT1rds/uisKyHIrobVcIKIoGXLW6fTZxcx58liBMg6Ef3vqK7NGEkJIOQVyDXGBQ6FW5DDBrf8LXDTaTGJDl48xk+uDivQws3flZw4qH2izGwIOTwKrXijg9eOoPIqypUsR0I9KguM4HB7njp9K6zlMhwFcKxywGCQeh/KqxO0EDkg9Tkj8asyHEuTvKDnIJ4qndDaxIbk+o7Vmy0RLwNgYIT/dAyafCWVmwAc9xkkU2Nj5wwxEnfI6/XFMgc+YQc/NwMj9OtQMtTgFsgDZtzlgP8ar3ChEIJI5wcd6tQqJIkEo4zwRk49sUqQsFUEOecgckfSnuIiiRSB5yblx8uAfzqUqVCqzhjgZXaM8HuaVkDRFht35x0/8Ar0KcxbivygYx1zjtQkI86UZJKhg45x2p8zgAHywcjlSOaYCochMBs4IPen52oEwvB4GSDXKaDWfbsPXHTJ6GkIdhuThScjpx9KciDlgrAHnAqYbdu5fm46HANMZD5ZYjd8rZ4LH/AOtSvGQ+4/KxPK9R7VKsq42hW3HsRkUxy3k7flHqpGaAEaNomBZUKHnpxTmCeXnLKR3HSogCyOHB4wQSOntzTVCqzA4G4c46UAanijJ02B855H8q45ua6nW7hJtCtthBO/acdsCuYKkmuav8R14f4R8C5ati1XGKzrZK1YRgcVijoL8HUVrWi9KyrYcitu1T5RWkUS2OulEkRVhwagutQLafFcOczwNsc+vvVi46VzV9Ls+3x9njDD6jNb052bRjVgpRudXp9z5rLjvXRRNhB9K4fwkzvaxNIfmwK65ZBjrXVB6XOKa1J5pMDPFU9+7ng02WTJxURbJwQQPWhsmwrZLDJ4zWfqsh2FAePar2SB61QCefLKx5GMVDLh3OU1khr2RgcggY/KsOb71bN+gR3XPQkVjyDLV59R6s9KGxLbDkVoxjpVK1HNaEI5FSimaNguWFdDAP3YFYunr8wrejGFFbQREiWPtWr4RbbZ3eegnfFZaVr+HlMejktjMjM2fqa6sMvfOXEv3TQjC4YgDcevFQXI3p1xnrxkGpYSTGCcZqrencTGCAB8wAxzXecRlTYOWKnYeMDqPxqi7ZY7uScY4zx+FWbl95KAgdCQMVVUtI+QeF6AGsJMtCxFyjMMHHQMMY/OnxLiNZFYlmflgN2f5U7opJXk+hGT+lSIgaJiArJgAlwc5pJDJ1QEgoCAOCxXPJ9KV0UhcqdynPAOKSMqGRgp2AfKD60+5YAsRgg44HarRJVl6sVGV2/NnAH5VEXZkiEJ+bPHy5x+dMdwrAyBxgYBHI/T+tQ7ypDIVfJ+6D/k1LYHHll5yrlvUdaVsKhYA7s9+c/nTYwTIqneXA6jpSPCBlwCZAQcnPFcxoOB2yM8TnDDgj19D6UJMrrJuTBPJHofWiONHkYoqncMgMcDNPjaNlxIhVxwcYGP8AGgCFgS25R82PvEU6KLBYSY3Yzg4GRUkgcMUIVVPAJB5/KgId3yqSuOc5yPx70WGV2KGP5ScDjB5xThgICSzIe4GcfSpmj8skkFjnGB1//VTDBIDkFeuec0AVNQ3BAmTsJ3AEY5rPZcVp3+CEYbgDngjpWW7Zb2rkrfEdtH4UWbftWhDyRWdb1p2wyRWaNTTs15rctx8tZNinzCtlF2pzW0ERIr3DVyWsPi9kA/iQLj8a6qduTXH6hum1cheikZpx3FPax12hqIrZMemK2VckZrG0/wCWJBjtWmmccdq61scMtyVWzwf0pQP9o/jTUTv+NPyc1RJFdPtXGeoqKwx5Dd81LOu5DTLdTEpHfrS6lLY5DWBtupR71iSD5q39dX/TJPesOUc151T4mejT+FElqOa0rcZas+1rVtxyKlFM1tPXkVuBcIKytMXLCtaQ8AV0R2M3uEYLHaOp4FdHGiw2Kw9BgLWHpqlryMYzzmty5PzeX95gM89q7MKtGzixL1SHr8ikHpjvVK+bK7vlG3nPerIc7Vz1xjk1n3BJnfKMDtwGUcmut7HMjIlfMgbGUYc8E/8A6qS3X5cN8ueN2cUsuWYt0VgcgripbZghUNhWcnjrj8qwtqWSkAIhDkMvGDkgVGJAjp5mQnQMBjJ981O8p28B88jBB21WZFCEk7WHX/a9s02IdvMSFRggEcjGD7YzQZRnPKDuB2/EVHFI73DBdgB7A9Py70Nkhk4K4zjOaLgVpAMODkIeTkZz7jmo4WK7RkxRjkYI/IClmAjyowjDOeBTFzxy/lbdpC88/QVDGcoxLfOh2uvbp9c0ESGLcwXGehOPyqZfllUsqehJ71DLFh+W5I4PBFYFDhGoAKnnjAYYzSyvwMbYzjpkHNMjRRGUd1Hp82RTwVTaPk5HIA+9QMaQudm3bnrjof8ACpFRCoVcqMde1RsflKtIpXI2hqWLO/HRR7Dj8aYDk2ICpG49Bg8/hTw7o5+U+Xn5iygkGlQfeV92ccjHT8aYCVZQxLJjgZzu/pTAo6mmzgAgHnk1lkc1s3mXC7u3H3QKoCH5q4q3xHbQfui269K1rRMkVTt4cAVr2kfIqEbM1dPi74q/McR1HZgLGM0646V0bIz3ZnzkBSSe1c7FHi5aQjO45yK3rw/umHrxWPGQSFC7Dt4xjn3FXSjdXMq0rOxu2bfKK1YunBrnbO7WOLc5yB1281r217BIMiVa3SOZmiCSOPxpcHBqAXMS8mROffrUY1GNpNkYLEVRJaCkjmkZCVxjpTY7gybSF69R3/D1qbkn5DvU9MCny3C9jlPEkRS5BIxuUGublGGrrPFYbZbljn7wBx2rlJetediFyzaPQoO8ES2talv1FZloK04OtZo1Zv6V1rRc5NZ+kjrV/vW62MnuWtPkEU4bGTjA+tX7dy4LO27vuIxWVCT5owQOO9ayKHiChduTnp3rvw/wnDXfvk0p3Rgrgp3A6mqU5Kxt/eI+VgP8asMFiRtmNueeO9UbiQHduwrdMnuK2bMUUlbZEruwYA5DHALe1LHvDFfuBTktngfpUb/vA4UuBnoc8VLM2VXI5xgtkY+mayKHPKmdqbCDyfXPtTChcBtzbPUAEE+gAqKDib5nAGTgBv8AD+lW45Bg4c7zyDgt+VPcBL8+WisrbSwHIGD9D71SuD+8X92vJzlRnJqxduJoMIuxeAwODyPfNUIVMbYZtq8gAnrSkxIfdOCUdgzHONynk/himFvnKoXVf4SV5+lNuByxEjBgPmU9vpQsajy94Vg2OwB/n1qWM5JVBYbiFb1FSgP5iqJCrHuOn8qRFZydw8vPOCenvmhUY4VlBCsehwfwNYFkO0ksQpLZxk8ZHvUuWQjDK575HAp+2MjeCdxGG5z+lR7YUidVLkg44GRRYBzSMoYOkbjPIJwRUqO/B3jYeOWwQag80qvIXGcdTn8xUi/LK/IJIxjPFNAPG4MF80r6Av3okwm0SOpI4PPSmZO35vu9iCc07zAYyXGV6E85P5dKYEFy6vGCik843VDEuTUl2c7OoP49KW2+9XJW1kdlH4S5BCMDir8C4IqOIfKKsIOalKxrcvwvhaSaTIqFScUjmncLFDUpMBFHGTyR2qi6kxgMcseTnHI/xqTUJt1yFGfl5zwfwquXAQbDkg85IBFddNWiclV3kSSuNilQygDA460ZZQQwyQOCOM+9RF8sBk+WORye/wClJGQTgKctzkYAP86pshIv2pyyBckE8Z4/LFW7YM0vRNpbB5PX61RgIIAYkADJ5NaenREShiFLHgqf/r/0qkSzd07buRWYbQPlLf09PxqWY4BVV2ndngA5HriktQqOCWbdgfK1NuXG5QJCCDxgjv8AWui2hl1MHxWqiKJYh+7RsA9uR2rl2TNdXr6BrJm+Tcrg5Awa55V46V5eKXvno4Z+4QwoVNaMA6U2KMNVqKPBrFI1ua+l8CrgNULJ9tXQa1i9CXuPzhgcMOwYVswHbbr6jqayUXerKQcYyTir1lIUtiCMenQ16NH4UefW+Jlif7hDAMCegx1rNfzNwzx6bsHr2rRnG0gk5DDCrjoay7hWkDYwSeoDEj6VcjNEbJ5xbIDOnfB6D2psbgQu6jao45I6n8KUHyiwTLRDqpBJ/WmRkBCI2KnqVBAqChUGSRG5Bxu4BOfyxT5GYRbT5gzyeM4+hzUUYZT5aljkDHGcH61ZjXJlIz0xtJUge59aEJlYl28oFWWM99wwfr6VYCMuQSiqQCuM4zUb7YwrZIUrg7TgfypxZUOFY9OTvzxQlYRTmBMrKNrluoAJGR3HanwBVjzk7R/GQOPpnnNRSSbzgFR3APP8/WnROWVUAYKTzhgD+FLqM5IZLMUJJ7sBlaYZAHHyqc8j5ev4VKwbe0kD4P8AdYcZqO4R2ciVCrYzhRj+Vc5Q/ByzFMA8bQuM0EkqSFYgjA4zx75qNAAVDAjj5SxGKdMAqHEoVj24IzQMb+7jIGCD+OCPzp0eGDjb3zls5P0qDy1IG8KrbfbH4U+QEBRLuZc8nAApoZaGDtKkr3JJNNCDPzbjnO0jPWiMbWIjZNo55HNTIQ65kA8zPBXg8e1UhFXUjuaMcdOo9aS2HzUl0rBk3NuzyDToD8wrjq/Gzso/CasQwoqwnamQr+7Bp68UmaImXpTJTgGnp0qvcttQn0FCQ2YFxKXmduQN3y45BPqcdKaGYbVZWyDnAPT8arM5aViVIOMZGSOasQkbiRlc45X/AArsXY433FaRcKuRtA7kZH+NPj3lGJJypyBUNwoI5AG4nnaOT9O1EeShBPyr3yf51LYI0rcggK5Yg8jc1bFiSrqRnccDGB09q5+KRP3bSbcZ6DpW1bODJmEvwOmOP/1VpFkSR0MTkIo5Zm/hPUAU+7VfIHzDA6DAPNQq5EKONzHGM/41I0u6NlHTAwPY10mRlXwRbC4iG3JGeTzkelc4hyK6i+yqMo3KjJ0bnn8RxXJqfWvPxa1TO3CvRouwnBFXV6VQtznFXV+7XOjd7lu3NaC9BWdaVoLwKcRMmRsSLn7vU+h9s1oQ7UTC/dPOQeazkXIy+RHjBcdq0ozuUIQAF4B/vV6VL4UefV+Jineihc78Hg56/X0qvcbckJkOevGDx79qc8mUdSSRnGDkZOelRupZTKWLAjGOTg1ozMpuQly0YZQWJOFxz+FV43KTA8egGeD+VWrgAszMwAC5BJ59wcjrVVtso+WUDB7Hj8cVmykWLcFQWfnqvAwR+BNWLY7I2JbOBht5HXtVSJm3r95kUklsg7j7jsasiUKSo284yADz+OOtOImJLM3klRllOBjuD7cc1TmlkYx+WTgg4ySN3/1/arkhwpMiyGMnadoJ571Sul3BsEED5hkHn/PtQwQxolt7gRli3mKOWHIJ9TVi0hfYUb58fwnnPbj1qpCW2bgN69xnB21owF0/1akbVyg29OOmaS1BnFyL8+3AJA+UYGRUfzrkAqAw4x1p8u5JB82455wv86YpJ3eaRn25I+lYFEIG0DYxXnLEgHNTbgjkEiRSucY6f/Wp7xRvguGZsZJKnP1pDb4AaEMQRkfNx/8AqpWGROxJyH2r68Y+lKHVQibmYH1bp+HpQoYna+cdCD0Bp0fHy5HHyneOKEAjsY5SZSdp4C5AxT43+YMiqRnADDr+tJ5ci4DcoOgLHGKSKBhuUqSDzlcGqQxlyFDpsORjn60+2GXFMnVVfC5B7g9RVixTc4rkqL3zrpP3DahA8kU0dalOFiAqJPvUSLiTL0rL1qTZaOOTnjitTtWNrgLWxwASDnpmnHcJbGJESpQfeK9sjJ/rVkAFRtOCvOTk/pVaLbvDbFJUYOCAPrUysOWU7sH++R/kV0nKMlJB2jgk8jn9KYMkHcQW7MAAR+Bp8shJBDHp1JzTIkj80MQdw5DcZP8AjUNlIuwuY3jEg3P1BHOfqBxWvpvBZyGD9Rhj19MVh+YrOp+67cZCEc+9atupRV4LcjHTKHvWkGRI6GCYuVDsCpGNuOlWJVKo0kZw+MHjO6suN1+XdGVYD7wAzx3qysjNMER8gKCU4+b8a6E9DFoknYzpIGyJNo3BQQCa5SRdsrr7966WWRXZmMZWQHlWU8jHsf1rn7sAXLbDkHBFcuKV4pnThX71iS345q2rcVTi6VZU1yLY6nuX7Or61QtOlX06VURSJ04RiHIbHy+hPpV6yYNE244HXB6VRgPP7s7gT8ynv9KulxHGSCXxxtzXp01ZI86bu2MkYBHHOFbDcZJ96g81FuOu2LHykjGT6MKZeuUx8oMR6gA5B9/SoIJjFcuHkysg6bec/QUN6kpEl5CzE7OAx5O5v6VUycGAB9vUkjkj/CrcajdhIyoZcsMfJ7GofISAEtFkso4UdPrUvUaY77jeYpkUtwBuVt341YG7KBXZ3I/vd/5VBEcsodDGrDB6Yz+VW7RHjfaSrBfUmmiWDKJXDMv3V4Oeh9x2qjdYAYhdjglXLAEH61bITcAy7gCc4yc57mqtyAYZFx8ofCMAPl9v/wBdNoEVVUG0V2LMgP3c4xz7VPGx8hwr7Ezk7VyW9OvvUS7huLtnnoW2/wAqltyYGUNtd5DyDnjj/PNQhnOI8ixldisD/F/jVdT8wOCv4knNWfMD4JJRCCcKRk/U0xyS3yHCHkFTWbQ0RlGMalsqATtPJJqIRowJjb5l7DJANSHIfqTu4JZuMe1RvuO1lwy4PLcZ9xUjRGWaNyX4PRwScfhTixCgArt+8CTz+HrUUgYYYLnj+8aNjsCQQyr69QfSkMmL43LG6FGGSvUZ+lQJnHlsBswMDdnjNIzFecsGA4w2CfrT0lUr8wQqCD1OR60XGOyzABiGUMQpHOR9avWHDVnxsjOShGDzgrgj/GtCz4asKi96500n7pqM3y9aFHNMByakHSpepsh/UVka5n7OdoYnI6da116Vl6wAYGB6Ej3qo7oUtmYikbPlUdegYZNEp2gnJyec5J/Opn4Ykfw/wkgfnVWVlBALYJ5xuPFdD0OVDfMLEBhgn2JzUifKBkgj2AGKhkLA5798E4p8Tc/KSOOQRgf41kyi5ECAdpyDxyDVy1OQfMBJx97b1x2xVJCrKNuc/XkVOrlXDNsPbIA4q4slmtFP8qlgQmeAe1WFYBxJ9188hcDI9ayjIrJgfMuc4BGBUkUhfYY5CoHVQQQa3UjNo1Jm3ztGuA23K/L/ACrDuCDdOB0BxwMYq60ocOFUbwMZIB4HPasuB/McsTyTmsMTLSxvh1rcur0qVDlqiXnipYxziuM6jRtD0rRQgDJ6VQtE6VoxZVl2kdec1tSjzMzqSsi2EWSUGP70bYXPOfwoWQxwsoOZhzhQcYpBl4SAOM4wTgfXNRzEENDwUA6kn9TXp7HnEM22SMkxscYbODz68VAcADysHbyyt0x605ztyrKGOc7R2/r/ACqWQgQhhtA25UjJyPpxWe49ia1KyRKXAeIHO3B3L/SorpSEV0I2k8fJUlm4DkMHIbuFwGx3z61BOGKPgcZ4UpnNPoT1ItxbCFyOOCBg1op5YmIzuO0YIJ61mRfeQnHmE8ggDA9a0IgNzYIJznJ5z9O1ERscy+XNulHzkEBsdD/Ws5iwMoPTr90YNXrt9yEN3GFLJhcen1rNjQg7I4mLHO48flTkSh2SkKgv8wXBXaSMfhV5CPJx8qkDOM4DcfpxUETYkCY++MHJJ2+1PdlV41DEpjB6c+vekkBzM6sqAbWTJyeny1WZdpO0Kx6rySD+VXyi7iOCWHUEdarlFBBTBc8gZx+grNoaZCEbchVmVTz1qN0+bKsWVhwQxqwQzEbcgPyRk9faowhkjO5hycHkg5qbFIpSKyuUBI4ydw5H0oUkNuAB24AwTg1YmiMS4ZCy5xjJJzUDo5I25A98jioKIZJMMQwABOclqgyFZhuYZGQQOKtPGdzBQzeuRnH5VWWFG/jYY4x3P4VJSZLbXDNGMxlz0yDzWpbH5qxGxH8oZiD1GM5rSsJVZBtOdvymoqLqbUn0NtO1SqagibKDHWpAcGszoLA6VQ1MZgf1HNXUOahvUzGfcVW2otzmZWCsX42kdTzUbZQA7iT78YzQAFk469Dg8UrfMSCScZHX9MV0PU5SJAeRxz046/UCnRxMfm345+6BxQmCTgscc9Oc1OoJbGSCf4hxWdhjlAIPzc9wR2pzMVAypXA+VgRn86cVAB2Ng+5xUFxIc4PJPQZBAP8ASgW45HJL/vcORjkAbx6VLA3yblZiVOPvYqmeWJwMd8cc/hUZmKZIO12BwSc1SkFjRmnJjOPnBzjdg4FV7adUYAmqzzFwSWXOKqb/AN5WFeWqOmhHRnSxurgFWBqxC/zYrDtMkjBNdBpsHmyAetZ77Gmxq2gJUEVcj4yQp3AY5wKakYiXA7UrDdHExIK88e3XmuzDx1uctd9CWElVJ+fjrl+B7026kEkeEyXBwCAefY0sUhMTKApJbAX7px71DcoN5KF1Y8McYz7c11N6HL1EjYCSNVCrLk5cfex3NLKUEe3zHI3cfMSAPQ4oXZLFksGIB+bAJP6VKpZv3ZQNGRtIZsn8MVKExVRjGqTZbaDweajlDsSI2bcPVQB9KWNBhvL3BozkjaQCKlBdGbCguFBXtgZ/WmuwimpxKwBwTxtLD+lXAp2MCc5IADgnmoPvSHpyMnLDH145pzyIYx948jbuJyvFNCY66JEagcY++pGc+uM1VBQkqrBSCQEY8DPTpT5ELyLuAPfJABz3/wD1UjKpnU4GEyxKNyfehgKjjy9kgwxwAM5z9T6VK6tLcBVLptXgDAAp87ocOdzIflBAIJ/zxUOwiPGSFIO7HGMdKdhGW0TwodoZm43B+lV3RSMou0g4OM9f896sJMzzFWbIxlR3b+tNcSMweRVBQ9M8DPqazsBVkRU5xywzx1z60jkjgA/N1O05/D2qTZgbSmOecZxUbblXk854wxP/AOoVLRSKrjjc4+gBPIqIM542/Kc/w+3rVmSPa4aTd6Bckg0zyywxIASTxx0/LrUtFJkGZlYA5IHPzL/I1A8WWJTH4qSR9avsjNFy2QBwOB07fWqyKWX7+Mep6VDQ0yk8R8s7AgODnAx+maksGIdgwIJ55XFSxZd2QMOOpAHNQ7THI3yEkEcjgj61EloawdmbdrIOhqVpADWMJyDxUyTFsZNYXOxI1UnwOtTykvbbqylbNaSHNnj0qou6BqxyzN+9ZQ5JJ6A07OSAdo/HrT70BLgrypzng9ajkG5cMeD3JrpvdHK9HYaE3MCSQPQsasR/utoG3B9eKgHLqR09sGrke0KA6gE9D6/hU2FcaxUjscdMVXbB/djjuAcEirZjB6gDjIz2qK4ALLxk8EMMYFIVypIhjzhtpPy57Z71BMp4xkg9S3erjpuJOfT7vTNU542jCjG1W6nNJlIhACqyqx59TmoQT5nPWpZBtjY5PTr61WgUu/Nc1bc6qOxv6cMgGur0hVVga5SwO0CuisJsYpw0ZUtTakJKkLgsTgZpFbESOAwdcg56CkhkB5xngjnoKaWXy1DRhj3JHX8M8V30vhucVX4rFgxF9mGIZFzxwDmmSyF0dXjaNg43MAOn1py5WIx7tgxuAzt2n6UzIKY3mPH3t3zA/U1qYD4QsMqvKCCeEPHzfXFIJS2WTaWHVtwxTUYFyN2FH8IGeaY+xivlNu5ywzjA+lPYTJELHcsDAbhuBYEkevNMQSBQEIUqTgFPb1p6OrBfNUh1JG0dQPXHpUX+rWRNo3NyGPAx+PSkSPiYNGWR8OOoOOajkcGZ8cxlcYLZFBcJLEVkA4weQpNNcsxOAGBOQFPJHpQAsUORhTsxgjYMH9atxFRGQzYPPO7H8qrxEJOoAxkEgg9vx61ZlAULtbccfKOx/LvVRQmRSrl16E9D83UYyDUcrtGwMaszEckDg/nQhbc4UEdWyTngelOYFomCLliec0bgZTgpIu4KSR1J5/DFJKu35VKAMMNvGA1TSMS+MkNgYzwP/wBdMkCnMcrlcLw3TmoBFcqHyp3BiM7gOKYYw5K/MXOcjkA1YlQCMkoDwMk9Mev1pPJDhAoOwDgt3zSGVGBRC4JXafmJHX6VA6liDEMbecMOefercqfvgWGFHHI/lUE21gUC4A4Y9KloaZW3bHymdo7kd/pUMm0lmAcAHvxmnvGMth+c4x2quxdPlCgjOMHqKzZaGuoV9w8sg8j1/GhphIDkYx1wMZNMKu7bUGMcY21G5ZQQcKQOp61LZa1ZOMHBqZCKopLwPWplk5HNch3IvK3StK0fMRWsVH5q7BME6mqi7Mb1RBqcQLB+hU9f8apyOeVG0ngcN0P5VqXJDrnrVLd8+IiuMcFq6Keqsc1VWdyFIijH5cnpwM/nWhBGoUHaU9T/APWqkB5TgLtQHGQR/WrsRcnHBB5G3HNWkZMWe3GMkjI6jFQFRGQCOSPYYq2FZCGBw2MHvxTVgUSEAsr4zkDINFhXKhQnJ8srgZwD15qnNHIwY4ILHoe1be1WAVA4UrjhQOfWq91GASpKAckkHkUco1I57Ul8uJVzgEdAahshVvWgSkXB6YyTnNJpsDMuR2rhqfGdtL4TQthjFbFocYrPtEDHAq5EQJCoPIoRbZtQMGXB71YLJLjcQsgGApx82Kz7d8EA1cUk8qyqeuWFdVGdtGc1aF1dD3LFGfa23k8HJBHXtT/LEzBmACtgqT3wOhp6MZCCEwrZG3BpZoT9yJ9jryFIzmuyxxXIguFR9qs2cYOBx68U8bSGQYkIyc7u3uaIgZArIAMHDqcEL6kUki7ZWZA3lOfmzn+VOwhfMZo925SQMEbc4HbmmdQVjUOWO7AGCD9TTjuVTuU+gjIySPekbdHEjK4YZPQdDTEVbRxcuY2Zg6kknODn/GrEis8aRKV3AblY9arbQJdytyc5HC/jVnehlWZl4UYAyTUoGPg2FSrx5YA5fHGfrT5sQuiuzBMAqBxkiooFbzWdGDxnJ2dOv1pL9lWMq7OFIymf5VS2JGFnMrecV2kYHU809VEEWAQAyZ68Z/pS2a5jjkkLZxxznBqG4cKo3Z355IG3Oe9C7gQuGcBgSpXqepz9KSPMibnO7b69fxApFJbzHbGxcYyfvGnseZHC7SRnC8ke4/wqbAQoodWjJXP3gB2P1qJMy45BKjptxz+NLIrY3LuEa8ttPXHtU3ykh8Yk2/eJ4wf0pDIpfnGSpQA9xjkVQkXe5Hy7c8jOKuXA5UqSuOB7fU1XkQlCWJGOoB7etJjRRfG8kKeeOuCajdtpGQCMdT7U6QcbiW4PBU5z71UeUjPB3EcVkzRC+YCGVCAvUAjvTLn5owSdzetRKSzkKDu7HNRsjJIuRx65/nWcndGkd0MzUkbfNT2iGM5quxKNiuPY7kX1bjOakRixHNVI23Hk4FXYSCvy8imO5fRQ0WapyAGRY8Af3cH+lNS5/e7QflqW4QlQV+8QcHODW9KWpjWV43IFPOMEOD1KfyqxFvJwGK+mCBmoUw4CuBu2/LtHSp4GkZGBBJXvwPyrc5S5B95TkOCcEDqPwqx9nW34YgOegyTTbVGfa2Ciheecn8asxKIVxGGLMTwT0rRIzbGSRcn5VLLzyDxmoJoeRIWOyQ4+XC4q8IfNkUHcQxxkE4/E02SMAlSOEzkkfLn1xVOIkzldciBIGzaQT3zUuloqWNwT/ChPT2q14giJijZSxB6c/wCeaoTb4fD945ByF4rgqxtUPQou8EO0eRpJefWrspMWqPGOTwc1V0RP3qM3Q4Nal7H/AMT4t/D5a/1qEtDRvUkncxTwqT99d361ogsDEcfe4rH1kn+0bTb08o/zrV35W2A4IPP5Va3JexrRrvCPIxAP8QJzSwhGlK/KuPu+p+tRK3lxx7+Azcc4zUgGbrG0kEZO/kj0NelHZHmS3ZJ5Rl6g8DouAM1WkmJkAfAi+7tB+b8amikbzMbiUVc52/z+lQyOpnDIQ2wcgYwatkCJ3JYqynkMCeM8DP8AWs+7JQsQBgHG0c5+lWPNk81sY2uMDnIx6GmRrmUrvLKgyKhspCI2BE5AWUYwD0IqeXA8xWZhtJyM4wfXFIBsC/dkZFPXvzn/ACaidzJbrK46nI5z360IRM5wUVRhwuDxz0609nEiFTtw3AxxyOarISFVjIrMTtbGckVYQK/3FxyCOmRQhEUZZEJnClcZ4zuGf50IqmQMwGAoKqw/x609gXmHmvlQvHHCn61I8SyhCcq4XcPXHqDT8guZzMf3cQXJ3ZG5+nrTiVO1QoUZ4B5BPrSfNMGVdvy4Cnpk06XzgrSMI0UDaCc5GaQivLl5SqEKmcZYnI/D0qQbUjlC7+R8wHRh7ZpCheMhc8sCcg4x3qV0TeWYN8vXg/h3pWGQyJ5cQ+b5Typ6Z+vvVJQxkBkbICksQMEZ+taSxNK7NKFjOOp7+/WoVhxJ87p5xHGeCf8AGk0CZmvD8xBX5QOu0DJqnJaMz8Y5GRj/ABrfMeBkAAnkEgnn2qu6ZwrkOp6Kq45qHEpSOeuItgJRgxA52jOKgclANxz2zgAj3rYltjvKquCBlhjr75qJ7dGgaRUYgN0bj8az5WaKRmyA+WjKTtbOKrzqSqeu6tMwbkYs4RVII6mi6td0GYxl154rlnScTshUUtCosZEQJzyQBWpp1uZEeP8AvKRSJEJNPbyxudcOB64rRsinyPEcqwzSUbM0voYenwmZVfuPlYehHWtS+jH2FuDkYPBxVk26xyhogAGJDcYGTzTbzBj8k8FxnmtYU3Fmc6kWmZMMZUhthKZ5HU5rTtmVMEYPbYTjIqjbpliqlcjuxyRitODcFUIV83GNu3BauiKOSTLao4njLjBAwoBwPofzq8LdREfMG49SGOee2KiRS+zYxUdOSDz681oPgKI2JYtwCSOa6IxMWyqUFwmV25PuSM0kjgArsZnH3XAwD7VLl1O04UKOuetVmPm3ErRNtZlAznIH+NNgihfxiWEKR83G0Fsn8Kq3Fl5tt5MuNr8EA5rYmkERChCFH8Te1Z1w29oiqyDPJ5HzVhOkm7s1hUlFWRDbWzB1WONiDyvHOK0JLJ3ZJlIbcAuO4xUdnIERCzhcH5eS3FasYMQYlBlm3YX07Y9KmNCLLdeRXOlrPscyYkUYGRwRmrMNhEs4DsWZQcAjg1amAYr+7y2M57fhQxUD5eXY8nv/APqrZUILoZOtN9SrIjMcOcE8DjpSQsEYkF2duM55X+lSzh0DYJ54Xj7tUX2+V5p+dh8n3sEmrtYzLM0rJA5Pyv1Vscn1HtUR8yX74UGQAr8oAx9aozSlmhDKZFUFfb8vWrYnaGFd3GM55+6O1K99BiDiTCMC653A8jGKlMYmTcVTqCQTkAVBEitGZHfcSQxBPWrSQK6MwRQx4KgdfWhCZXEREIDOcA5QEdKSX94wIXBHITfxmpchisbMp7jIxj2zUDboSWdgWH8JwM0WASJlQsiAFyASMck9wDWhGmAQRllwVx2qqiBoxK+MkA7fbNPdvLZGABLDhgOlCBhNIGOGLZwQVyBu/CnOqsFjYBXA+U5PHtSKFeQMwXsQRUJk23ILg5+5gHNMQMUkkQF14TKhTxkUgJui8chznnMYwCBTbcecJd2AQSAVABAq0kKl0h52Y3dfakIiGIIgqlli5QYHI9wRUDtbrC8bMQxIwACCfSmXb7Icqq/NkkduKnjUJEjDJJBOD270AQsQpQxr8mMMDz3okiyzNtLgtncB0HXipH+ZpHGVZwCdpIpYyxmVC2VdiTwO1K1xjWQmBPLzsc5OeuPrUSp5mHQ8rwCG4qdHYg84AYgAcdqitxtRiGbqB1pNARTRxs+H3fMMMEBOahABDqiSLGAcptxuq8I1zu5z6Z4NQQsZJNrY2gnAAqbFIoCMu8bZ3AjGw/w1L9iliAcBCVPAJ+9n1NaRgT7MBggbhkDgHJqSaIRLKQzE5A+Y5p8txqRlC2aCZvLUsOuNwxmmwLIJidoC5w23oM961TGC7AZACjAHGKpxZKyszE7SAB2pckV0K9pImhtcs+5iSTlVLcY9frVfUVG6PDqBjP45rUcbYVZeD1zVSeMHGSTxjrVtaEJ6mM6KGJG3lsHJ5xmrsTsGVVhOQepGcf1qucu0gJOE6YNMgffcR5AwwOcVmWblixkQtLxt53Y61osoSFix8yQAHjqKqW+FTAAx5ZI46YNWpeDbrn5XIUit4rQyb1K+9pJsSYHHzZIBGaY7AW+1cHB+9nmpGAF2gHTcc+/WlkG3OCfu5/WgClLG7hhnEpxkgcGqcxUxjzkMfO0/X/Crd45jeQL0BBx9RWVcNuRXKru3DtWctC4mhbou8Kg3bcEhcdPetC3mdEcSgYydpXmqdudkMDADc/DEjrUthIzmWPOAowCBz1pxEzUdt0BIUqewPGKjDh1UP82Bye9STKN7nnKhSPxFU5ZCZAAANykEj6VqSNkklVSjkhQeOeSPUVVdgy+Un8RGM5IHvTrYGUlZGZtitgn/AD709xgKQTgdB25rJu4ylFhJXjuAWwPvgZwc1dmO+ORnk2FCCAeNwxx1p7QqsUrLkMmGB98VBdHYUBw+1Qw3DJoSGFmpE0qSHORuBAyOnQitC3Cm1UA42k4INVGTzJk3M3U9Djtmp7RzLbKzcEOF44yM1USWyKdvLUBt2885A4BHrUNyu+VXfGzqecgVauv9cU7Hr+dV7peflJXbwMemBxQ0AkmwS7o/n4CkA+tPt/njkD71cNj2/GoYE5kGT1DfrT5mP9qCEcKg4I6/j+dIZbcrCvKk8YbBx7EVVWLfEDkgcjBORirjqDaJKeZOTn6VXlH7p5V+VkwRjp09KbJP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pressing on the chest for CPR is called doing \"compressions.\" To do compressions on an infant using the 2-finger method, make sure the victim is on a flat, solid surface. Then place the tips of your index and middle fingers on the victim's breastbone, just below the nipples. With each compression, make sure the victim's chest drops down at least 1.5 inches (3.8 centimeters). Between compressions, lift all pressure off the victim's chest so that his or her chest goes back to where it was.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40914=[""].join("\n");
var outline_f39_61_40914=null;
var title_f39_61_40915="Iodoquinol: Patient drug information";
var content_f39_61_40915=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Iodoquinol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/38/21091?source=see_link\">",
"     see \"Iodoquinol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/44/26306?source=see_link\">",
"     see \"Iodoquinol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Yodoxin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F183811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Diodoquin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691909",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702314",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to iodine, iodoquinol, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695847",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take after meals.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017567\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11973 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-66B715A8D5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40915=[""].join("\n");
var outline_f39_61_40915=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183810\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183811\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017564\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017563\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017568\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017569\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017571\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017566\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017567\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017572\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017573\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?20/38/21091?source=related_link\">",
"      Iodoquinol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/44/26306?source=related_link\">",
"      Iodoquinol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_61_40916="Sweet syndrome plaques on forehead";
var content_f39_61_40916=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Sweet syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous, edematous plaques are present on the face.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40916=[""].join("\n");
var outline_f39_61_40916=null;
var title_f39_61_40917="Keratosis follicularis spinulosa decalvans face";
var content_f39_61_40917=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratosis follicularis spinulosa decalvans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous, small keratotic follicular papules and cicatricial (scarring) alopecia involving the eyebrow are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40917=[""].join("\n");
var outline_f39_61_40917=null;
var title_f39_61_40918="Pemphigus vulgaris - oral";
var content_f39_61_40918=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57924%7EPC%2F59594&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57924%7EPC%2F59594&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris - oral lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions on the&nbsp;palate in a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Paraneoplastic pemphigus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erosive mucositis in a&nbsp;patient with paraneoplastic pemphigus associated with Castleman's tumor; mucous membrane and cutaneous lesions cleared with tumor removal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Chris Ha, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40918=[""].join("\n");
var outline_f39_61_40918=null;
var title_f39_61_40919="Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients";
var content_f39_61_40919=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40919/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40919/contributors\">",
"     Gary M Cox, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40919/contributors\">",
"     John R Perfect, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40919/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40919/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40919/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40919/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/61/40919/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated cryptococcosis is a serious opportunistic infection that occurs in patients with untreated AIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/1\">",
"     1",
"    </a>",
"    ]. Although cryptococcal infection begins in the lungs, meningitis is the most frequently encountered manifestation of cryptococcosis among those with advanced immunosuppression. However, the infection is more properly characterized as \"meningoencephalitis\" rather than meningitis since the brain parenchyma is almost always involved on histologic examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of cryptococcal meningoencephalitis in AIDS patients will be reviewed here. Treatment and monitoring of AIDS patients with cryptococcal meningoencephalitis is found elsewhere. The microbiology, clinical manifestations, and treatment of this infection in other patient populations, such as transplant patients, are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19494?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cryptococcal meningoencephalitis in HIV seronegative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15210?source=see_link\">",
"     \"Treatment of cryptococcal meningoencephalitis and disseminated infection in HIV seronegative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13449?source=see_link\">",
"     \"Cryptococcal infection outside the central nervous system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/24/37254?source=see_link\">",
"     \"Microbiology and epidemiology of cryptococcal infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/23/23929?source=see_link\">",
"     \"Treatment of cryptococcal meningoencephalitis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/42/38568?source=see_link\">",
"     \"Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Globally, it is estimated that approximately 957,900 cases of cryptococcal meningoencephalitis occur each year, resulting in more than 600,000 deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The region with the highest number of estimated cases in 2006 was sub-Saharan Africa (720,000 cases; range, 144,000 to 1.3 million), followed by South and Southeast Asia (120,000 cases; range, 24,000 to 216,000) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/4\">",
"     4",
"    </a>",
"    ]. A low CD4 cell count is the main predictor of risk of cryptococcal meningoencephalitis; the vast majority of cases occur among AIDS patients with a CD4 cell count &lt;100",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </span>",
"   </p>",
"   <p>",
"    The incidence of cryptococcal meningoencephalitis has declined in patients who have access to antiretroviral therapy (ART) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/6\">",
"     6",
"    </a>",
"    ]. However, cryptococcal disease remains a leading cause of mortality in the developing world where access to ART is limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346466\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of cryptococcal meningoencephalitis typically begin indolently over a period of one to two weeks. The most common symptoms are fever, malaise, and headache [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/2\">",
"     2",
"    </a>",
"    ]. Stiff neck, photophobia, and vomiting are seen in one-fourth to one-third of patients. Patients rarely present with coma and fulminant death in days.",
"   </p>",
"   <p>",
"    Other symptoms suggesting disseminated disease include cough, dyspnea, and skin rash [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/8\">",
"     8",
"    </a>",
"    ]. Visual and hearing loss have also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346473\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial physical examination may be notable for lethargy or confusion in association with fever. In one report, 24 percent of patients had altered mentation on presentation, and 6 percent presented with focal neurologic deficits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/2\">",
"     2",
"    </a>",
"    ]. Other manifestations of disseminated disease may be evident, including tachypnea and skin lesions resembling molluscum contagiosum (",
"    <a class=\"graphic graphic_picture graphicRef69214 \" href=\"mobipreview.htm?34/15/35058\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/8\">",
"     8",
"    </a>",
"    ]. Increased diastolic hypertension may be reflective of increased intracranial pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346480\">",
"    <span class=\"h2\">",
"     Laboratories",
"    </span>",
"    &nbsp;&mdash;&nbsp;General laboratory studies are nonspecific. Patients with advanced immunosuppression may have leukopenia, anemia, hypoalbuminemia, and an increased gamma globulin antibody fraction.",
"   </p>",
"   <p>",
"    The cerebrospinal fluid (CSF) profile classically demonstrates a low white blood cell count in the CSF (eg, &lt;50",
"    <span class=\"nowrap\">",
"     cells/microL)",
"    </span>",
"    with a mononuclear predominance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/11\">",
"     11",
"    </a>",
"    ]. The CSF protein may be slightly elevated, while the glucose concentrations are commonly low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/10\">",
"     10",
"    </a>",
"    ]. Approximately 25 to 30 percent of patients with culture-proven cryptococcal meningoencephalitis have a normal CSF profile [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typically, the fungal burden of organisms is generally higher, and the cerebrospinal fluid (CSF) inflammatory response is lower than in non-AIDS patients with cryptococcal meningoencephalitis. The higher the serum antigen load, the greater the fungal disease burden.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346083\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical diagnosis can be difficult given the subacute onset of symptoms and nonspecific presentation. A high index of suspicion should be maintained in patients with advanced HIV infection (CD4 cell count &lt;100",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     )",
"    </span>",
"    who have isolated fever and headache. The definitive diagnosis of cryptococcal meningoencephalitis is made through culture of Cryptococcal neoformans from the CSF.",
"   </p>",
"   <p>",
"    A presumptive diagnosis of cryptococcal meningoencephalitis is made in the patient with fever and headache who has a reactive serum cryptococcal antigen. A lumbar puncture is required to obtain CSF for confirmational testing after neuroimaging. (See",
"    <a class=\"local\" href=\"#H346135\">",
"     'Importance of neuroimaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A lumbar puncture is also important for determining the patient&rsquo;s intracranial pressure (ICP), which is associated with significant morbidity and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/2,10\">",
"     2,10",
"    </a>",
"    ]. The management of ICP is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/42/38568?source=see_link&amp;anchor=H645246#H645246\">",
"     \"Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis\", section on 'Monitoring of intracranial pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346135\">",
"    <span class=\"h2\">",
"     Importance of neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to a lumbar puncture, all AIDS patients with suspected cryptococcal meningoencephalitis must have neuroimaging (eg, computed tomography [CT] scan or magnetic resonance imaging [MRI]). Patients with evidence of increased ICP, suggested by loss of cerebral sulci, should not undergo a lumbar puncture due to the risk of herniation; such patients should be treated empirically.",
"   </p>",
"   <p>",
"    Imaging can also detect cryptococcal-associated hydrocephalus, which may require ventricular shunt placement. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/42/38568?source=see_link&amp;anchor=H645246#H645246\">",
"     \"Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis\", section on 'Monitoring of intracranial pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mass lesions in the central nervous system (CNS) due to C. neoformans are rarely seen in patients with HIV infection; other diagnoses, such as toxoplasmosis, lymphoma, and tuberculosis, should be considered in this clinical scenario [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H125300754\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346384\">",
"    <span class=\"h2\">",
"     Cryptococal culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;CSF should be sent for cryptococcal culture; cream-colored mucoid colonies are seen on agar plates generally within three to seven days. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125300827\">",
"    <span class=\"h2\">",
"     India ink staining",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the burden of organisms is usually high in AIDS patients, an India ink preparation of the CSF will usually demonstrate typical round encapsulated yeast organisms consistent with cryptococcus in more than 75 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/16\">",
"     16",
"    </a>",
"    ]. The advantage of the India ink preparation is that a diagnosis of cryptococcal infection can be made rapidly while confirmatory testing is being performed (eg, CSF culture or antigen). India ink stains should be reviewed by a microbiologist who is familiar with the physical characteristics of the organism.",
"   </p>",
"   <p>",
"    Regardless of India ink results, a cryptococcal antigen should also be performed for confirmation of the diagnosis and for an estimate of prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H346537\">",
"     'Prognostic factors'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cryptococcal antigen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryptococcal antigen can be detected in serum and CSF through immunodiagnostic techniques, such as latex agglutination or sandwich enzyme-linked immunosorbent assay (ELISA). The lateral flow assay using urine, serum, or plasma samples compares favorably with the latex agglutination and ELISA, and it is simple and inexpensive to perform [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/17\">",
"     17",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Spinal fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryptococcal polysaccharide antigen in the CSF is an important adjunctive tool to India ink stain of the CSF. Results of the antigen test can be obtained immediately after the lumbar puncture is performed. A positive antigen test can suggest the presence of infection well before the cultures become positive.",
"   </p>",
"   <p>",
"    The antigen test is very sensitive and specific in the CSF. In a study of four latex agglutination assays and one enzyme linked immunoassay, all performed well with sensitivities ranging from 93 to 100 percent and specificities from 93 to 98 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/18\">",
"     18",
"    </a>",
"    ]. False positive tests can result from infection due to the fungus Trichosporon asahii (formerly T. beigelii) or bacteria of the Stomatococcus and Capnocytophaga genera [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. These positive results are usually present with low titers. False positive CSF cryptococcal antigen results have been reported rarely following exposure of samples to disinfectants or soap, or after samples were placed into an anaerobic transport vial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/47/1785?source=see_link\">",
"     \"Infections due to Trichosporon species and Blastoschizomyces capitatus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Serum",
"    </span>",
"    &nbsp;&mdash;&nbsp;In AIDS patients with suspected cryptococcal meningoencephalitis, the sensitivity of serum antigen testing is comparable to CSF testing and is a useful diagnostic modality in patients who cannot undergo lumbar puncture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening with serum cryptococcal antigen may also be of high clinical utility in areas where cryptococcal infection is endemic. In Cambodia, for example, cryptococcal antigen screening among 327 HIV-infected patients with advanced immunosuppression demonstrated a prevalence of 18 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/26\">",
"     26",
"    </a>",
"    ]. Of the 59 patients diagnosed with cryptococcal infection, more than one-fourth did not have symptoms suggestive of cryptococcal meningitis. These data suggest that screening may be beneficial in identifying earlier disease in patients with advanced immunosuppression who live in endemic areas.",
"   </p>",
"   <p>",
"    Antigen titers generally correlate with organism burden. However, titers are not helpful in management of acute disease in HIV-infected patients since changes in titer do not correlate with clinical response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/27\">",
"     27",
"    </a>",
"    ]. Also, the slope of decline is not helpful in predicting those patients who may relapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/42/38568?source=see_link&amp;anchor=H14913531#H14913531\">",
"     \"Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis\", section on 'Laboratory monitoring for fungal infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Extraneural cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of cryptococcal disease is occasionally made only after C. neoformans is recovered from another body site, such as blood, urine, or sputum. Routine blood cultures may be positive for cryptococci in approximately two-thirds of AIDS-associated cases of meningoencephalitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/2\">",
"     2",
"    </a>",
"    ]. If cryptococcemia is suspected, fungal isolator tubes can be ordered for improved sensitivity.",
"   </p>",
"   <p>",
"    The prostate gland is recognized as an extraneural site from which cryptococci can reside, leading to relapse with systemic dissemination after discontinuation of treatment. Detection of cryptococcus on urine culture can be improved with prostatic massage. Prior to the era of potent antiretroviral therapy (ART), persistent prostatic sequestration of cryptococcus was described in patients who were treated for six weeks with amphotericin with or without",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32773?source=see_link\">",
"     flucytosine",
"    </a>",
"    , with subsequent relapse after treatment discontinuation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30530261\">",
"    <span class=\"h2\">",
"     Point-of-care testing in resource-limited settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preliminary data on novel point-of-care lateral flow assays with samples of urine, serum, or plasma show excellent correlation with more expensive methods (eg, latex agglutination testing and enzyme-linked immunosorbent assays) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/17\">",
"     17",
"    </a>",
"    ]. This simple dipstick test has the potential to improve diagnostic testing in resource-limited settings, which often have no access to centralized laboratory facilities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125300754\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis in the advanced AIDS patient with fever and headache includes toxoplasmosis, tuberculosis meningitis, lymphoma, syphilis, and progressive multifocal leukoencephalopathy. Patients with toxoplasmosis may also have focal findings, such as right hand weakness, while patients with cryptococcal meningoencephalitis usually have focal cranial neuropathies. Patients with tuberculosis meningitis may also have other clues to the diagnosis, such as cough, hemoptysis, and an abnormal chest x-ray. Patients with secondary syphilis with aseptic meningitis usually have normal mentation and a disseminated maculopapular rash. Those with central nervous system (CNS) lymphoma may have focal neurologic deficits with abnormal neuroimaging reflecting an intracranial tumor. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37017?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of early syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/22/33129?source=see_link\">",
"     \"Toxoplasmosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/3/26681?source=see_link\">",
"     \"Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H346537\">",
"    <span class=\"h1\">",
"     PROGNOSTIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for patients with AIDS-associated central nervous system (CNS) cryptococcosis has improved dramatically with antifungal treatment coupled with potent antiretroviral therapy (ART), which leads to effective viral suppression and immunologic recovery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Treatment of cryptococcal meningitis and the timing of ART are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/23/23929?source=see_link\">",
"     \"Treatment of cryptococcal meningoencephalitis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/42/38568?source=see_link\">",
"     \"Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute mortality ranges from 6 to 15 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/11,30,32,33\">",
"     11,30,32,33",
"    </a>",
"    ]. The significant clinical and laboratory predictors of death during the initial few weeks of treatment include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40919/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abnormal mental status",
"     </li>",
"     <li>",
"      Cerebrospinal fluid (CSF) antigen titer &gt;1:1024",
"     </li>",
"     <li>",
"      CSF white blood cell count",
"      <span class=\"nowrap\">",
"       &lt;20/microL",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Abnormal mental status on baseline examination or a deterioration of mental status can reflect increased intracranial pressure (ICP). Raised ICP should be considered an urgent medical issue requiring prompt intervention. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/42/38568?source=see_link&amp;anchor=H645246#H645246\">",
"     \"Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis\", section on 'Monitoring of intracranial pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36729160\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cryptococcosis is an invasive fungal infection caused by Cryptococcus neoformans. Infection begins in the lungs; meningoencephalitis is the most frequently encountered manifestation of cryptococcosis in HIV-infected patients. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The incidence of cryptococcal meningoencephalitis has declined in patients who have access to antiretroviral therapy (ART). However, cryptococcal disease remains a leading cause of mortality in the developing world. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms typically begin indolently over a period of one to two weeks. The most common symptoms are fever, malaise, and headache. Other symptoms, suggesting disseminated disease, may be present including cough, dyspnea, and skin rash. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The definitive diagnosis of cryptococcal meningoencephalitis is made by culture of the organism from the cerebrospinal fluid (CSF). A positive cryptococcal polysaccharide antigen in the CSF or serum strongly suggests the presence of infection well before the cultures become positive. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiographic imaging of the brain should be performed prior to lumbar puncture to rule out the possibility of increased intracranial pressure (ICP) or other space-occupying lesions. (See",
"      <a class=\"local\" href=\"#H346135\">",
"       'Importance of neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The significant clinical and laboratory predictors of death during initial therapy include an abnormal mental status, a CSF antigen titer of 1:1024, and a pleocytosis of &lt;20",
"      <span class=\"nowrap\">",
"       cells/microL.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H346537\">",
"       'Prognostic factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/1\">",
"      Bamba S, Lortholary O, Sawadogo A, et al. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy. AIDS 2012; 26:1039.",
"     </a>",
"    </li>",
"    <li>",
"     Cox GM, Perfect JR. Cryptococcus neoformans var neoformans and gattii and Trichosporon species. In: Topley and Wilson's Microbiology and Microbial Infections, 9th Ed, Edward LA (Ed), Arnold Press, London 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/3\">",
"      Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 1996; 27:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/4\">",
"      Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/5\">",
"      Desalermos A, Kourkoumpetis TK, Mylonakis E. Update on the epidemiology and management of cryptococcal meningitis. Expert Opin Pharmacother 2012; 13:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/6\">",
"      Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/7\">",
"      Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS 2007; 21:2119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/8\">",
"      Murakawa GJ, Kerschmann R, Berger T. Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature. Arch Dermatol 1996; 132:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/9\">",
"      Rex JH, Larsen RA, Dismukes WE, et al. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine (Baltimore) 1993; 72:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/10\">",
"      Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000; 30:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/11\">",
"      Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 2004; 363:1764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/12\">",
"      Darras-Joly C, Chevret S, Wolff M, et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis 1996; 23:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/13\">",
"      Garlipp CR, Rossi CL, Bottini PV. Cerebrospinal fluid profiles in acquired immunodeficiency syndrome with and without neurocryptococcosis. Rev Inst Med Trop Sao Paulo 1997; 39:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/14\">",
"      S&aacute;nchez-Portocarrero J, P&eacute;rez-Cecilia E. Intracerebral mass lesions in patients with human immunodeficiency virus infection and cryptococcal meningitis. Diagn Microbiol Infect Dis 1997; 29:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/15\">",
"      Troncoso A, Fumagalli J, Shinzato R, et al. CNS cryptococcoma in an HIV-positive patient. J Int Assoc Physicians AIDS Care (Chic) 2002; 1:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/16\">",
"      Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/17\">",
"      Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis 2011; 53:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/18\">",
"      Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994; 32:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/19\">",
"      Chanock SJ, Toltzis P, Wilson C. Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen. Lancet 1993; 342:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/20\">",
"      McManus EJ, Jones JM. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol 1985; 21:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/21\">",
"      Westerink MA, Amsterdam D, Petell RJ, et al. Septicemia due to DF-2. Cause of a false-positive cryptococcal latex agglutination result. Am J Med 1987; 83:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/22\">",
"      Blevins LB, Fenn J, Segal H, et al. False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol 1995; 33:1674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/23\">",
"      Boom WH, Piper DJ, Ruoff KL, Ferraro MJ. New cause for false-positive results with the cryptococcal antigen test by latex agglutination. J Clin Microbiol 1985; 22:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/24\">",
"      Wilson DA, Sholtis M, Parshall S, et al. False-positive cryptococcal antigen test associated with use of BBL Port-a-Cul transport vials. J Clin Microbiol 2011; 49:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/25\">",
"      Asawavichienjinda T, Sitthi-Amorn C, Tanyanont V. Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis. J Med Assoc Thai 1999; 82:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/26\">",
"      Micol R, Lortholary O, Sar B, et al. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr 2007; 45:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/27\">",
"      Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1994; 18:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/28\">",
"      Aberg JA, Watson J, Segal M, Chang LW. Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease. HIV Clin Trials 2000; 1:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/29\">",
"      Larsen RA, Bozzette S, McCutchan JA, et al. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. Ann Intern Med 1989; 111:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/30\">",
"      Lortholary O, Poizat G, Zeller V, et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006; 20:2183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/31\">",
"      Lanoy E, Guiguet M, Bentata M, et al. Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score. Neurology 2011; 76:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/32\">",
"      Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992; 326:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40919/abstract/33\">",
"      Robinson PA, Bauer M, Leal MA, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999; 28:82.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3757 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-1AFF26D322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40919=[""].join("\n");
var outline_f39_61_40919=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36729160\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346466\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346473\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346480\">",
"      Laboratories",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346083\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346135\">",
"      Importance of neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H346384\">",
"      Cryptococal culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125300827\">",
"      India ink staining",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cryptococcal antigen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Spinal fluid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Serum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Extraneural cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30530261\">",
"      Point-of-care testing in resource-limited settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125300754\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H346537\">",
"      PROGNOSTIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36729160\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3757\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3757|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/15/35058\" title=\"picture 1\">",
"      Disseminated cryptococcosis - papules",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/42/38568?source=related_link\">",
"      Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19494?source=related_link\">",
"      Clinical manifestations and diagnosis of cryptococcal meningoencephalitis in HIV seronegative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13449?source=related_link\">",
"      Cryptococcal infection outside the central nervous system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/47/1785?source=related_link\">",
"      Infections due to Trichosporon species and Blastoschizomyces capitatus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/24/37254?source=related_link\">",
"      Microbiology and epidemiology of cryptococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37017?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of early syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/3/26681?source=related_link\">",
"      Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/22/33129?source=related_link\">",
"      Toxoplasmosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15210?source=related_link\">",
"      Treatment of cryptococcal meningoencephalitis and disseminated infection in HIV seronegative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/23/23929?source=related_link\">",
"      Treatment of cryptococcal meningoencephalitis in HIV-infected patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_61_40920="Pain control in the critically ill adult patient";
var content_f39_61_40920=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pain control in the critically ill adult patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40920/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40920/contributors\">",
"     Karen J Tietze, PharmD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40920/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40920/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40920/contributors\">",
"     Stephanie B Jones, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40920/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40920/contributors\">",
"     Kari G Doucette, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/61/40920/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Critically ill patients may experience pain that is due to their underlying illness or injury, surgery or the result of other nonsurgical intervention. Pain may also be the result of a variety of noxious stimuli present in the critical care setting from monitoring (eg, arterial catheter, central venous catheter), therapeutic devices (eg, ventilator), or routine nursing care (eg, turning). Although some patients may be able to verbally or nonverbally communicate their pain control needs, the critically ill, intubated patient may not communicate their level of pain adequately. Pain control in the critical care setting is often inadequate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The primary goal of analgesia is optimizing patient comfort; however, attenuation of the negative physiologic responses to pain including hypermetabolism, increased oxygen consumption, hypercoagulability, and alterations in immune function are secondary goals that may be particularly important in severely ill patients. Control of anxiety and delirium, particularly in intubated patients, should also be addressed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The physiology and treatment of pain in the critical care setting will be reviewed here. The treatment of agitation and the use of sedative and neuromuscular blocking medications are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/29/15833?source=see_link\">",
"     \"Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/44/43720?source=see_link\">",
"     \"Use of neuromuscular blocking medications in critically ill patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=see_link\">",
"     \"Prevention and treatment of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physiologic pathways producing pain are well understood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/6\">",
"     6",
"    </a>",
"    ]. The patient senses pain through the afferent pain pathway (",
"    <a class=\"graphic graphic_figure graphicRef74589 \" href=\"mobipreview.htm?19/43/20146\">",
"     figure 1",
"    </a>",
"    ) and, under normal circumstances, the sensation of pain prompts the individual to avoid further noxious stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/7\">",
"     7",
"    </a>",
"    ]. However, avoidance of painful stimuli is frequently not possible for the patient in the intensive care unit.",
"   </p>",
"   <p>",
"    Tissue damage due to illness, injury or surgery initiates the release of local inflammatory mediators such as bradykinin, substance P, prostaglandins, potassium, histamine and serotonin (",
"    <a class=\"graphic graphic_figure graphicRef63962 \" href=\"mobipreview.htm?12/39/12927\">",
"     figure 2",
"    </a>",
"    ). These mediators can produce augmented sensitivity to stimuli in the area surrounding an injury (hyperalgesia) or misperception of pain to non-noxious stimuli (allodynia) (",
"    <a class=\"graphic graphic_figure graphicRef53674 \" href=\"mobipreview.htm?19/18/19748\">",
"     figure 3",
"    </a>",
"    ). Mechanisms contributing to hyperalgesia and allodynia include sensitization of the peripheral pain receptors (primary hyperalgesia) and increased excitability of central nervous system neurons (secondary hyperalgesia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some patients with neuropathy or myopathy secondary to drugs (eg, corticosteroids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    , nondepolarizing neuromuscular blockers) and those who have chronic pain syndromes may experience exacerbation of pain during critical illness through similar mechanisms.",
"   </p>",
"   <p>",
"    Analgesics reduce the sensation of pain by altering perception of pain in the central nervous system (eg, opiate analgesics,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ), inhibiting local pain mediator production (eg, blockade of prostaglandin synthesis by nonsteroidal antiinflammatory drugs), or interrupting neural impulse in the spinal cord (eg, neuraxial block). In critically ill patients, alleviation of pain is predominantly accomplished via central mechanisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ASSESSMENT AND MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most reliable indicator of pain intensity is what the patient reports. Even so, conscious and interactive patients have a varying threshold for reporting the presence of pain and, thus, caregivers must routinely assess pain and document its severity to identify its presence, provide treatment and judge responses to treatment.",
"   </p>",
"   <p>",
"    Patient questionnaires, visual analog scales and numerical rating scales are commonly used to assess pain. Visual analog scales grade pain using a continuous scale. The patient makes a mark anywhere along a line from zero (the absence of pain) to a maximum that represents the worst possible pain (usually 10) (",
"    <a class=\"graphic graphic_form graphicRef82442 \" href=\"mobipreview.htm?42/4/43084\">",
"     form 1",
"    </a>",
"    ). With numerical rating scales, the awake patient chooses a number from zero to ten yielding discrete data points. While these tools may be clinically useful, no scale has been validated in critically ill ventilated patients.",
"   </p>",
"   <p>",
"    Assessment and treatment of pain is more complicated in semiconscious or noncommunicative patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/11\">",
"     11",
"    </a>",
"    ]. Pain should be suspected in the presence of grimacing, writhing, or signs of sympathetic activation such as tachycardia, hypertension, tachypnea, diaphoresis, and piloerection. Behavioral physiologic scales take these pain-related behaviors and physiologic indicators into account to rate the level of pain. Although behavioral-physiologic scales correlate somewhat with other pain scales in experimental settings, the parameters are nonspecific and may be due to other factors. Several objective pain rating tools have been developed for use with nonverbal critically ill patients. Two of the scales, the Behavioral Pain Scale (BPS) and the Critical Care Pain Observation Tool (CPOT), are valid and reliable tools, although neither is yet considered a standard pain assessment tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In critically ill patients, pain is often underestimated and therefore undertreated. Alternatively, the level of pain might be overestimated when based upon physiologic responses. Nevertheless, the clinician should err on the side of presuming that pain is present and provide treatment whenever the patient cannot help in the assessment of pain, whenever signs of pain are conflicting, or whenever pain cannot be differentiated from other issues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/3,13,14\">",
"     3,13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"    The ideal agent for treating pain and optimizing patient comfort would have a rapid onset, rapid recovery, lack of drug accumulation and no side effects or toxicity. Unfortunately, no single agent has all these characteristics. Thus, ongoing monitoring of the patient&rsquo;s pain level, response to medication and potential development of side effects is important and should be frequent enough to maintain an acceptable comfort level. For conscious patients, a pain rating of 3 or less out of 10, or 2 or less out of 5, has been suggested as a desirable goal of analgesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. However, analgesic goals are patient-specific and depend upon the clinical situation, and patient tolerance of pain and side effects. Some patients may prefer to tolerate some pain to maintain a degree of alertness whereas others will not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INTRAVENOUS ANALGESIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous administration of analgesics is more commonly used in critically ill patients because gastrointestinal dysfunction can lead to unpredictable absorption of medications. If gastrointestinal function is intact and the patient is tolerating tube feedings, administration of oral analgesic agents (liquid formulation) through the feeding tube may be an alternative.",
"   </p>",
"   <p>",
"    Intravenous administration is generally preferred over subcutaneous or intramuscular routes due to potentially erratic or inadequate absorption due to regional hypoperfusion (eg, shock, subcutaneous edema).",
"   </p>",
"   <p>",
"    Pain control may be more consistent if analgesics are administered continuously or scheduled as intermittent boluses compared with &ldquo;on demand&rdquo; dosing. Supplemental analgesia can be given as needed. This strategy is most useful when pain is ongoing or predicted to continue for a period of time. Pain that is event-related or resolving is better managed with demand dosing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4720958\">",
"    <span class=\"h2\">",
"     Opioids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mainstay of pain control in critically ill patients is intravenous opioids such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"     hydromorphone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    . Opiates are drugs that have opium or morphine-like properties, whereas opioids refer to any agent with activity at the opiate receptor, including agonists, antagonists, and mixed agonist-antagonists. At least four discrete opiate receptors have been identified in the brain (",
"    <a class=\"graphic graphic_table graphicRef52205 \" href=\"mobipreview.htm?1/29/1499\">",
"     table 1",
"    </a>",
"    ). Currently available opioid analgesics function via binding to the mu (&micro;) receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2983493\">",
"    <span class=\"h3\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opiate agents provide swift and potent analgesia when administered parenterally. There are no differences in analgesic effect between different opioid agents provided they are given in equianalgesic doses; however, pharmacokinetics, metabolism, and side effects vary. Opioid tolerance refers to a phenomenon where exposure to an opioid has a diminished effect over time. Patients who develop tolerance may require higher doses for effective pain management. It is important to titrate to pain relief. There is no maximum dose or duration of administration of an opioid.",
"   </p>",
"   <p>",
"    Intravenous opiates can be delivered in three different ways: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bolus intravenous injections are often used for moderate pain, with doses titrated to analgesic requirements and avoidance of respiratory depression and hemodynamic instability. Bolus doses of opioids should always be given prior to bedside procedures that may cause pain with additional dosing given during the procedure, as needed.",
"     </li>",
"     <li>",
"      Continuous intravenous infusions of opiates are used for moderate-to-severe pain that is poorly controlled with repeated bolus injections. After an initial bolus dose, a low continuous infusion rate is set with subsequent adjustment for adequate analgesia.",
"     </li>",
"     <li>",
"      Patient-controlled analgesia (PCA) may be preferable in conscious patients, particularly in the postoperative setting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/18\">",
"       18",
"      </a>",
"      ]. This technique allows self-dosing with opiates up to a predetermined limit set by the clinician. An underlying basal rate can be initiated at the same time or added later using the patient-selected dosing to determine the need for and dose of basal infusion. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27546?source=see_link&amp;anchor=H21#H21\">",
"       \"Management of postoperative pain\", section on 'Patient controlled analgesia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no trials comparing the various opioids to each other in critically ill patients. The choice of agent depends upon the desired onset and duration of action and the potential adverse effects of the agent. The risk versus benefit of opioid analgesia administration must be considered for each patient. Reduced dosing or avoidance of opioids altogether may be needed in some patient populations. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Assessment and monitoring'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4721198\">",
"     'Opioid side effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Guidelines for the sustained use of analgesics in critically ill adults have been established by the Society of Critical Care Medicine (SCCM) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/19\">",
"     19",
"    </a>",
"    ]. For parenteral analgesia,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"     hydromorphone",
"    </a>",
"    are most commonly used. Specific dosing guidelines are discussed below for the individual agents.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       Fentanyl",
"      </a>",
"      provides the most rapid onset of analgesia and is preferred for relief of acutely distressing pain.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       Fentanyl",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"       hydromorphone",
"      </a>",
"      are recommended instead of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      for patients with renal insufficiency or hemodynamic instability.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       Fentanyl",
"      </a>",
"      may be preferred in the presence of bronchospasm.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       Morphine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"       hydromorphone",
"      </a>",
"      are preferred for intermittent bolus therapy over",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      due to their longer duration of action.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2983458\">",
"    <span class=\"h3\">",
"     Specific agents",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h4\">",
"     Morphine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     Morphine",
"    </a>",
"    is the prototype opiate and remains widely used in the intensive care unit. The onset of analgesia is rapid, with the peak effect occurring in one to two hours with an elimination half-life of three to five hours. After hepatic conjugation to glucuronide metabolites, renal elimination usually occurs within 24 hours.",
"   </p>",
"   <p>",
"    At least one",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    metabolite (morphine-6-glucuronide) shares its &micro;-receptor-stimulating properties [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/20\">",
"     20",
"    </a>",
"    ]. Renal failure permits accumulation of this active metabolite [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/21\">",
"     21",
"    </a>",
"    ], and dose adjustment is necessary to avoid oversedation and respiratory depression if renal function is impaired (creatinine clearance less than 30",
"    <span class=\"nowrap\">",
"     mL/min).",
"    </span>",
"   </p>",
"   <p>",
"    The Society for Critical Care Medicine (SCCM) guidelines recommend intermittent intravenous bolus doses of 0.01 to 0.15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every one to two hours, and continuous intravenous infusion doses of 0.07 to 0.50",
"    <span class=\"nowrap\">",
"     mg/kg/hr.",
"    </span>",
"    Doses must be titrated to the desired effect and patients monitored closely for drug-associated adverse effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4721198\">",
"     'Opioid side effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h4\">",
"     Fentanyl",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     Fentanyl",
"    </a>",
"    is a synthetic derivative of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    and is approximately 100 times more potent. It is also more lipid-soluble than morphine, and therefore has improved penetration of the blood-brain barrier which leads to a more rapid onset of action and a shorter half-life than morphine at two to three hours. Compared with other opioids, fentanyl is virtually devoid of histamine-releasing properties. Clinically significant histamine release rarely occurs with fentanyl dosages up to 50",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    and, thus, fentanyl may be preferred in the presence of hemodynamic instability or bronchospasm. (See",
"    <a class=\"local\" href=\"#H4721198\">",
"     'Opioid side effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     Fentanyl",
"    </a>",
"    is metabolized in the liver by the cytochrome P450 3A4 isoform to norfentanyl, an inactive metabolite. Norfentanyl and other inactive metabolites are excreted in the urine. Renal failure does not appear to affect its pharmacokinetics.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     Fentanyl",
"    </a>",
"    is highly lipophilic with rapid distribution to many tissues (brain, heart, kidney, gastrointestinal tract, skin) and a slower redistribution to muscle and fat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/22\">",
"     22",
"    </a>",
"    ]. These stores are mobilized following the cessation of the drug and may result in prolonged sedation.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     Fentanyl",
"    </a>",
"    usually is administered as a continuous intravenous infusion. Alternatively, intravenous boluses every 0.5 to 1 hour may be given, although this method is less convenient and may allow breakthrough pain to occur. Fentanyl can also be administered via a transdermal route. Due to the delay in time to peak effect after application (12 to 24 hours), transdermal fentanyl should",
"    <strong>",
"     not",
"    </strong>",
"    be used for the management of acute pain in the critically ill patient. However, hemodynamically stable patients with chronic analgesic needs may benefit from this route of administration, which generally provides consistent drug delivery.",
"   </p>",
"   <p>",
"    The SCCM guidelines recommend intermittent intravenous bolus doses of 0.35 to 1.50",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    every 0.5 to 1 hour, and continuous intravenous infusion doses of 0.7 to 10",
"    <span class=\"nowrap\">",
"     mcg/kg/hr.",
"    </span>",
"    Doses must be titrated to the desired effect and patients monitored closely for drug-associated adverse effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h4\">",
"     Hydromorphone",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"     Hydromorphone",
"    </a>",
"    (eg, Dilaudid&reg;) is a semisynthetic opiate agonist which, like",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    , has a more rapid onset of analgesia (within 30 minutes) and a shorter half-life (2.4 hours) than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    . Because it is available in a highly concentrated preparation (10",
"    <span class=\"nowrap\">",
"     mg/mL),",
"    </span>",
"    it may be beneficial in fluid-restricted patients with greater opiate requirements.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"     Hydromorphone",
"    </a>",
"    is primarily metabolized in the liver to a glucuronidated conjugate, which is excreted in the urine along with small amounts of the parent drug and other inactive 6-hydroxy reduction metabolites. The effect of renal insufficiency on the elimination of hydromorphone is unknown.",
"   </p>",
"   <p>",
"    For control of moderate-to-severe pain, 0.2 to 0.6 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"     hydromorphone",
"    </a>",
"    is administered as an intravenous bolus every two to three hours. In mechanically ventilated patients, hydromorphone also can be administered as a continuous intravenous infusion starting at 0.5 to 1 mg per hour after the initial bolus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h4\">",
"     Fentanyl derivatives",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/47/15094?source=see_link\">",
"     Sufentanil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/9/3223?source=see_link\">",
"     alfentanil",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/50/5927?source=see_link\">",
"     remifentanil",
"    </a>",
"    are derivatives of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    . Sufentanil is 10 times more potent than fentanyl making it 1000 times more potent than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/23\">",
"     23",
"    </a>",
"    ]. Remifentanil has an analgesic potency approximately equal to fentanyl, whereas alfentanil is one-fourth to one-third as potent as fentanyl. Due to their rapid onset of action (within two to three minutes of an injection) and short elimination half-lives (approximately 90 minutes), fentanyl derivatives (unlike fentanyl) are nearly always used as adjuncts to anesthesia or immediate postoperative analgesia with little use in the intensive care setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27546?source=see_link&amp;anchor=H12#H12\">",
"     \"Management of postoperative pain\", section on 'Parenteral opioids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4721198\">",
"    <span class=\"h3\">",
"     Opioid side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioids are given cautiously to critically ill patients. Patients should be monitored closely for drug-associated adverse effects and followed for any changes in renal or hepatic function which may alter drug metabolism.",
"   </p>",
"   <p>",
"    All opiates share common side effects. These include depression of the respiratory drive, depressed consciousness, hallucinations, hypotension (more common in hypovolemic patients and following rapid injection), nausea and vomiting due to direct stimulation of the chemoreceptor trigger zone, ileus and urinary retention.",
"   </p>",
"   <p>",
"    All opioid narcotics act directly on blood and tissue cells to release histamine. Histamine release may produce flushing, tachycardia, hypotension, pruritus and bronchospasm. The amount of histamine released is inversely correlated with potency. The greatest histamine release has been reported with large doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    and the least with small doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/47/15094?source=see_link\">",
"     sufentanil",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/24\">",
"     24",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Avoidance of opioid analgesics or decreased dosing may be needed for patients with underlying respiratory conditions (eg, chronic obstructive pulmonary disease). Renal or hepatic dysfunction alters drug elimination and, therefore, increases the risk of opioid-associated respiratory depression.",
"   </p>",
"   <p>",
"    Due to the central and peripheral vasodilatory effect on the cardiovascular system, opioids increase the volume of fluid used during resuscitation which may have negative consequences in certain patient populations (eg, trauma, burns). Alternative analgesic medications should be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/25\">",
"     25",
"    </a>",
"    ]. Opioids may also increase intracranial pressure in patients with traumatic brain injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastrointestinal transit slows with prolonged opioid administration, resulting in ileus and constipation in many patients probably due to binding to local opiate receptors in the gut [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Gastric motility may be impaired more than small bowel motility and, therefore, patients receiving enteral nutrition may benefit from postpyloric placement of feeding tubes. Peripheral opioid-receptor antagonists (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/29/2516?source=see_link\">",
"     methylnaltrexone",
"    </a>",
"    ), may be useful in treating opioid-induced bowel dysfunction while preserving central analgesia because the drug does not cross the blood-brain barrier [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/7/5236?source=see_link\">",
"     Alvimopan",
"    </a>",
"    (Entereg&reg;), an oral peripherally acting mu-opioid receptor antagonist, is used to accelerate gastrointestinal recovery following bowel resection. However, this and other opioid-receptor antagonists have not been studied in critically ill patients and remain investigational. &nbsp;",
"   </p>",
"   <p>",
"    Acute opioid withdrawal has been described in critically ill opioid-na&iuml;ve patients receiving moderate to high-dose opioid analgesia for more than one week and is due to neuroadaptation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/31\">",
"     31",
"    </a>",
"    ]. Symptoms of opioid withdrawal include drug craving, patient request for more drugs, nausea, abdominal cramps, or muscle aches. Signs of opioid withdrawal include fever, hypertension, tachycardia, tachypnea, sweating, lacrimation, vomiting, diarrhea, or seizures (",
"    <a class=\"graphic graphic_table graphicRef81045 \" href=\"mobipreview.htm?21/47/22267\">",
"     table 2",
"    </a>",
"    ). Nonverbal patients may appear restless, irritable, dysphoric, anxious, delirious, or have increased pain sensitivity. In critically ill patients, these symptoms and signs may be nonspecific. When opioid withdrawal is suspected, opioid dosing should be temporarily increased or a longer-acting opioid can be used. These measures should resolve the signs and symptoms of withdrawal and, thereafter, opioids can be tapered over a longer period of time.",
"   </p>",
"   <p>",
"    To minimize the likelihood of withdrawal symptoms, various daily dose decrement weaning strategies (eg, 5 to 25 percent per day) have been suggested, but all are empiric. Some clinicians empirically convert patients who received opiates for greater than one week to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/32\">",
"     32",
"    </a>",
"    ]. Methadone use is reserved for this special circumstance and should not be used as a first line medication to manage pain in the critically ill patient. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4722332\">",
"    <span class=\"h2\">",
"     Non-opioid analgesics",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4721530\">",
"    <span class=\"h3\">",
"     Ketamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"     Ketamine",
"    </a>",
"    , an N-methyl-D-aspartate (NMDA) receptor antagonist, in sub-hypnotic doses (&lt;5",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per min), has been reported to provide effective analgesia and sedation in a small number of patients inadequately controlled with high doses of narcotics and benzodiazepines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Additional data are needed to establish the efficacy and safety of ketamine in critically ill patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4722257\">",
"    <span class=\"h3\">",
"     Paracetamol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral paracetamol (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ) is an effective analgesic and antipyretic agent that can be used for the short-term treatment of moderate pain and fever in critically ill patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]. The mechanism and dosing of parenteral paracetamol is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27546?source=see_link&amp;anchor=H1277062#H1277062\">",
"     \"Management of postoperative pain\", section on 'Intravenous acetaminophen'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4722525\">",
"    <span class=\"h3\">",
"     NSAIDs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsteroidal anti-inflammatory drugs (NSAIDs) nonselectively inhibit cyclooxygenase, a potent inflammatory mediator. Although NSAIDs are less appropriate for the acute management of pain in critically ill patients, they may be used as adjuncts to opioid therapy. The NSAIDs may have opioid-sparing properties, but this has not been adequately studied in critically ill patients. It is unknown whether outcome measures (eg, ventilator weaning, return of bowel function) are improved with NSAIDs to enough of an extent to outweigh their associated risks (eg, gastrointestinal bleeding, renal dysfunction).",
"   </p>",
"   <p>",
"    In the United States,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/62/35808?source=see_link\">",
"     ketorolac",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    injection are available for use. All parenteral NSAIDs should be used with caution in patients with preexisting renal insufficiency, hypoperfusion or those who are elderly. They are avoided altogether in patients with asthma or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    sensitivity. When used, treatment should be limited to the lowest effective dose for the shortest period of time, not to exceed five days.",
"   </p>",
"   <p>",
"    Labeling for all parenteral NSAIDs includes black box warnings regarding the increased risk of gastrointestinal irritation, bleeding, ulcers and perforations and increased risk of adverse cardiovascular thrombotic events, including myocardial infarction and stroke. The adverse effects of NSAIDs are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/49/17177?source=see_link\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4722532\">",
"    <span class=\"h2\">",
"     Not used in critically ill patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Not all parenteral analgesics are appropriate for critically ill patients. Some analgesics are not recommended for routine management of pain in critically ill patients due to lower potency",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    safety issues. These agents include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    , and opiate agonist-antagonists (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9543?source=see_link\">",
"     butorphanol",
"    </a>",
"    , dezocine,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/45/14038?source=see_link\">",
"     nalbuphine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/48/29446?source=see_link\">",
"     pentazocine",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     Codeine",
"    </a>",
"    has a low analgesic potency when administered parenterally. Most of its analgesic effect is due to hepatic metabolism to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    and therefore time to effect is slow.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     Meperidine",
"    </a>",
"    is not superior to morphine and a normeperidine metabolite that is eliminated via a renal mechanism has neurotoxic effects that may include seizures and delirium.",
"   </p>",
"   <p>",
"    Opiate agonist-antagonists (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9543?source=see_link\">",
"     butorphanol",
"    </a>",
"    , dezocine,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/45/14038?source=see_link\">",
"     nalbuphine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/48/29446?source=see_link\">",
"     pentazocine",
"    </a>",
"    ) can precipitate withdrawal in chronic opiate users or in patients who have received prolonged administration of opiates.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"     Methadone",
"    </a>",
"    has an extended duration of activity which increases the risk of drug accumulation and, therefore, adverse effects with repeated dosing. Methadone can also prolong the QT interval leading to torsades de pointes. Methadone may, however, be useful for weaning patients who have demonstrated withdrawal symptoms. (See",
"    <a class=\"local\" href=\"#H4721198\">",
"     'Opioid side effects'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4721948\">",
"    <span class=\"h1\">",
"     NEURAXIAL ANALGESIA AND PERIPHERAL NERVE BLOCK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not commonly used as a primary modality for analgesia in critically ill medical patients, the critically ill surgical patient may benefit from analgesia provided by neuraxial analgesia or peripheral nerve block, which may have been initiated in the operating room, to control incisional pain. Neuraxial anesthesia and peripheral nerve blocks are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=see_link\">",
"     \"Overview of anesthesia and anesthetic choices\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/37/5719?source=see_link\">",
"     \"Overview of peripheral nerve blocks\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4721683\">",
"    <span class=\"h1\">",
"     NONPHARMACOLOGIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep deprivation and anxiety decrease pain threshold and increase patient stress. Lack of sleep may also alter tissue repair and impair cellular immunity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/40\">",
"     40",
"    </a>",
"    ]. Thus, it is essential to minimize stimuli which can disturb normal diurnal sleep patterns, such as noise, artificial lighting, unpleasant ambient temperature, frequent vital signs or invasive procedures. Other nonpharmacologic interventions include minimizing irritating stimuli (eg, traction on the endotracheal tube) and uncomfortable positioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/19\">",
"     19",
"    </a>",
"    ]. Prompt treatment of anxiety and delirium is also important [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/6,41\">",
"     6,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=see_link\">",
"     \"Prevention and treatment of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sedative-hypnotics should not be used routinely to manage pain in critically ill patients because of a lack of non-oral dosage forms, unpredictable oral absorption, potential drug accumulation and alteration of mental status. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/29/15833?source=see_link\">",
"     \"Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4723685\">",
"    <span class=\"h2\">",
"     Complementary therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complementary therapies are low cost, safe, and easy to provide, though data regarding efficacy in critically ill patients are limited. These therapies are based upon the gate control theory of pain in which these interventions are believed to inhibit ascending transmission of noxious stimuli from the periphery or stimulate descending inhibitory control from the brain. Although theoretically desirable, many complementary therapies are not appropriate for critically ill patients due to hemodynamic instability that could be brought on by physical manipulation or potential negative impact on mechanical ventilation or other equipment. For less critically ill patients, relaxation therapy may improve sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Music decreases analgesic requirements in some operative settings, and may also be a useful adjunct in critically ill patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. A systematic review identified 51 randomized trials evaluating music intervention but few studies included critically ill patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/45\">",
"     45",
"    </a>",
"    ]. The authors concluded that listening to music reduces pain intensity levels and opioid requirements but the overall magnitude of the difference in pain with and without music is small. Another trial evaluating the effect of music during routine turning of intensive care unit patients did not find a significant benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40920/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4720653\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain is an unpleasant sensation due to a variety of causes. The critically ill patient may not be able to adequately communicate their level of pain and, as such, pain control in the critical care setting is often inadequate. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assessment of pain in conscious and interactive patients is commonly accomplished with patient questionnaires, visual analog and numeric rating scales. Assessment of pain is more complicated in semiconscious or noncommunicative patients. Pain should be suspected in the presence of signs of discomfort (eg, grimacing, writhing) or sympathetic activation (eg, tachycardia, hypertension). The degree of pain often is underestimated and the clinician should err on the side of assuming the patient is in pain. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Assessment and monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mainstay of pain control in critically ill patients is the administration of intravenous opioids including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"       hydromorphone",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      . Fentanyl provides the most rapid onset of analgesia. For critically ill patients with renal insufficiency or hemodynamic instability, we suggest fentanyl or hydromorphone over morphine (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Fentanyl may also be preferred in the presence of bronchospasm. (See",
"      <a class=\"local\" href=\"#H4720958\">",
"       'Opioids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We prefer to use intravenous administration of analgesics over intramuscular or subcutaneous administration in critically ill patients because of unpredictable absorption due to variability in regional muscle or skin perfusion. For patients with ongoing pain, analgesia is more consistent if medications are administered continuously or scheduled as intermittent boluses compared with &ldquo;on demand&rdquo; dosing. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Intravenous analgesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other parenteral agents that may become useful for controlling pain in intensive care unit patients include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      and paracetamol; however, additional studies are needed to determine their effectiveness and safety in this subset of patients. Intravenous NSAIDs can be used in some patients as a short-term adjunct to other analgesic agents; however, NSAIDs are associated with an increased risk of cardiovascular thrombotic events and gastrointestinal complications including gastritis, bleeding, ulcers and perforation. (See",
"      <a class=\"local\" href=\"#H4722332\">",
"       'Non-opioid analgesics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although medication is central to pain management, environmental factors in the intensive care unit contribute to a lowered pain threshold by causing anxiety, sleep deprivation and stress. Control of these factors may lessen pain perception and lower pain medication requirements. (See",
"      <a class=\"local\" href=\"#H4721683\">",
"       'Nonpharmacologic therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/1\">",
"      A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995; 274:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/2\">",
"      Mularski RA. Pain management in the intensive care unit. Crit Care Clin 2004; 20:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/3\">",
"      Freire AX, Afessa B, Cawley P, et al. Characteristics associated with analgesia ordering in the intensive care unit and relationships with outcome. Crit Care Med 2002; 30:2468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/4\">",
"      van de Leur JP, van der Schans CP, Loef BG, et al. Discomfort and factual recollection in intensive care unit patients. Crit Care 2004; 8:R467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/5\">",
"      Stevens DS, Edwards WT. Management of pain in mechanically ventilated patients. Crit Care Clin 1994; 10:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/6\">",
"      Carr DB, Goudas LC. Acute pain. Lancet 1999; 353:2051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/7\">",
"      Lewis KS, Whipple JK, Michael KA, Quebbeman EJ. Effect of analgesic treatment on the physiological consequences of acute pain. Am J Hosp Pharm 1994; 51:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/8\">",
"      Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth 2001; 48:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/9\">",
"      Woolf CJ, Chong MS. Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/10\">",
"      Suzuki H. Recent topics in the management of pain: development of the concept of preemptive analgesia. Cell Transplant 1995; 4 Suppl 1:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/11\">",
"      Hamill-Ruth RJ, Marohn ML. Evaluation of pain in the critically ill patient. Crit Care Clin 1999; 15:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/12\">",
"      Li D, Puntillo K, Miaskowski C. A review of objective pain measures for use with critical care adult patients unable to self-report. J Pain 2008; 9:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/13\">",
"      Hamill-Ruth RJ. Use of analgesics in the intensive care unit: who says it hurts? Crit Care Med 2002; 30:2597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/14\">",
"      Erstad BL, Puntillo K, Gilbert HC, et al. Pain management principles in the critically ill. Chest 2009; 135:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/15\">",
"      Murray MJ, Plevak DJ. Analgesia in the critically ill patient. New Horiz 1994; 2:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/16\">",
"      Caswell DR, Williams JP, Vallejo M, et al. Improving pain management in critical care. Jt Comm J Qual Improv 1996; 22:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/17\">",
"      Sessler CN, Varney K. Patient-focused sedation and analgesia in the ICU. Chest 2008; 133:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/18\">",
"      Chumbley GM, Hall GM, Salmon P. Patient-controlled analgesia: an assessment by 200 patients. Anaesthesia 1998; 53:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/19\">",
"      Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/20\">",
"      Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther 1989; 251:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/21\">",
"      Peterson GM, Randall CT, Paterson J. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration. Eur J Clin Pharmacol 1990; 38:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/22\">",
"      Bj&ouml;rkman S, Stanski DR, Harashima H, et al. Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model. J Pharmacokinet Biopharm 1993; 21:255.",
"     </a>",
"    </li>",
"    <li>",
"     Yaksh TL, Wallace MS. Opioids, Analgesia, and Pain Management. In: Goodman and Gilman&rsquo;s The Pharmacological Basis of Therapetuics, 12th ed, Brunton, LL.  (Eds), McGraw Hill Medical, New York.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/24\">",
"      Flacke JW, Flacke WE, Bloor BC, et al. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987; 66:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/25\">",
"      Wibbenmeyer L, Sevier A, Liao J, et al. The impact of opioid administration on resuscitation volumes in thermally injured patients. J Burn Care Res 2010; 31:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/26\">",
"      de Nadal M, Munar F, Poca MA, et al. Cerebral hemodynamic effects of morphine and fentanyl in patients with severe head injury: absence of correlation to cerebral autoregulation. Anesthesiology 2000; 92:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/27\">",
"      Alban&egrave;se J, Viviand X, Potie F, et al. Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit Care Med 1999; 27:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/28\">",
"      Sun EA, Snape WJ Jr, Cohen S, Renny A. The role of opiate receptors and cholinergic neurons in the gastrocolonic response. Gastroenterology 1982; 82:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/29\">",
"      Murphy DB, Sutton JA, Prescott LF, Murphy MB. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology 1997; 87:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/30\">",
"      Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358:2332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/31\">",
"      Cammarano WB, Pittet JF, Weitz S, et al. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998; 26:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/32\">",
"      Kress JP, Pohlman AS, Hall JB. Sedation and analgesia in the intensive care unit. Am J Respir Crit Care Med 2002; 166:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/33\">",
"      Edrich T, Friedrich AD, Eltzschig HK, Felbinger TW. Ketamine for long-term sedation and analgesia of a burn patient. Anesth Analg 2004; 99:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/34\">",
"      De Pinto M, Jelacic J, Edwards WT. Very-low-dose ketamine for the management of pain and sedation in the ICU. J Opioid Manag 2008; 4:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/35\">",
"      Duggan ST, Scott LJ. Intravenous paracetamol (acetaminophen). Drugs 2009; 69:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/36\">",
"      de Maat MM, Tijssen TA, Br&uuml;ggemann RJ, Ponssen HH. Paracetamol for intravenous use in medium--and intensive care patients: pharmacokinetics and tolerance. Eur J Clin Pharmacol 2010; 66:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/37\">",
"      Hersch M, Raveh D, Izbicki G. Effect of intravenous propacetamol on blood pressure in febrile critically ill patients. Pharmacotherapy 2008; 28:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/38\">",
"      Gozzoli V, Treggiari MM, Kleger GR, et al. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med 2004; 30:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/39\">",
"      Avellaneda C, G&oacute;mez A, Martos F, et al. The effect of a single intravenous dose of metamizol 2 g, ketorolac 30 mg and propacetamol 1 g on haemodynamic parameters and postoperative pain after heart surgery. Eur J Anaesthesiol 2000; 17:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/40\">",
"      Krachman SL, D'Alonzo GE, Criner GJ. Sleep in the intensive care unit. Chest 1995; 107:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/41\">",
"      Tembo AC, Parker V. Factors that impact on sleep in intensive care patients. Intensive Crit Care Nurs 2009; 25:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/42\">",
"      Richardson S. Effects of relaxation and imagery on the sleep of critically ill adults. Dimens Crit Care Nurs 2003; 22:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/43\">",
"      Richards KC. Effect of a back massage and relaxation intervention on sleep in critically ill patients. Am J Crit Care 1998; 7:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/44\">",
"      Koch ME, Kain ZN, Ayoub C, Rosenbaum SH. The sedative and analgesic sparing effect of music. Anesthesiology 1998; 89:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/45\">",
"      Cepeda MS, Carr DB, Lau J, Alvarez H. Music for pain relief. Cochrane Database Syst Rev 2006; :CD004843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40920/abstract/46\">",
"      Cooke M, Chaboyer W, Schluter P, et al. The effect of music on discomfort experienced by intensive care unit patients during turning: a randomized cross-over study. Int J Nurs Pract 2010; 16:125.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2888 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-218.189.88.190-EF2F3CD7BB-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40920=[""].join("\n");
var outline_f39_61_40920=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4720653\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ASSESSMENT AND MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INTRAVENOUS ANALGESIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4720958\">",
"      Opioids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2983493\">",
"      - General principles",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2983458\">",
"      - Specific agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Morphine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Fentanyl",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hydromorphone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Fentanyl derivatives",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4721198\">",
"      - Opioid side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4722332\">",
"      Non-opioid analgesics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4721530\">",
"      - Ketamine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4722257\">",
"      - Paracetamol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4722525\">",
"      - NSAIDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4722532\">",
"      Not used in critically ill patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4721948\">",
"      NEURAXIAL ANALGESIA AND PERIPHERAL NERVE BLOCK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4721683\">",
"      NONPHARMACOLOGIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4723685\">",
"      Complementary therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4720653\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/2888\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2888|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/43/20146\" title=\"figure 1\">",
"      Mechanism of acute pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/39/12927\" title=\"figure 2\">",
"      Nociceptor sensitization following tissue injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/18/19748\" title=\"figure 3\">",
"      Peripheral chemical mediators of pain and hyperalgesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2888|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"mobipreview.htm?42/4/43084\" title=\"form 1\">",
"      Visual analog pain scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2888|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/29/1499\" title=\"table 1\">",
"      Opiate receptor activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/47/22267\" title=\"table 2\">",
"      Clinical features of opioid withdrawal",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27546?source=related_link\">",
"      Management of postoperative pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/49/17177?source=related_link\">",
"      Nonselective NSAIDs: Overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=related_link\">",
"      Overview of anesthesia and anesthetic choices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/37/5719?source=related_link\">",
"      Overview of peripheral nerve blocks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=related_link\">",
"      Prevention and treatment of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/29/15833?source=related_link\">",
"      Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/44/43720?source=related_link\">",
"      Use of neuromuscular blocking medications in critically ill patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_61_40921="Evaluation of female infertility";
var content_f39_61_40921=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of female infertility",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40921/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40921/contributors\">",
"     Wendy Kuohung, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40921/contributors\">",
"     Mark D Hornstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40921/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40921/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/61/40921/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/61/40921/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/61/40921/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An infertility evaluation is usually initiated after one year of regular unprotected intercourse in women under age 35 and after six months of unprotected intercourse in women age 35 and older. However, the evaluation may be initiated sooner in women with irregular menstrual cycles or known risk factors for infertility, such as endometriosis, a history of pelvic inflammatory disease, or reproductive tract malformations.",
"   </p>",
"   <p>",
"    The basic evaluation can be performed by an interested and experienced primary care physician or an obstetrician-gynecologist. The primary care physician generally should refer the patient to a specialist for treatment of infertility. Many gynecologists initiate treatment prior to referral to a reproductive endocrinologist. This decision depends upon the results of infertility tests and clinician experience.",
"   </p>",
"   <p>",
"    Multiple tests have been proposed for evaluation of female infertility. Some of these tests are supported by good evidence, while others are not. This topic will provide an evidence-based approach to the evaluation of female infertility. The etiology and treatment of female infertility, as well as the etiology, evaluation, and treatment of male infertility, are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/56/17287?source=see_link\">",
"       \"Overview of infertility\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/18/3367?source=see_link\">",
"       \"Causes of female infertility\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/5/14425?source=see_link\">",
"       \"Overview of treatment of female infertility\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/54/11114?source=see_link\">",
"       \"Causes of male infertility\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33481?source=see_link\">",
"       \"Evaluation of male infertility\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3610?source=see_link\">",
"       \"Treatment of male infertility\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INITIAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both partners of an infertile couple should be evaluated for factors that could be impairing fertility. The infertility specialist then uses this information to counsel the couple about the possible etiologies of their infertility and to offer a treatment plan targeted to their specific needs.",
"   </p>",
"   <p>",
"    It is important to remember that the couple may have multiple factors contributing to their infertility; therefore, a complete initial diagnostic evaluation should be performed to detect the most common causes of infertility, if present. When applicable, evaluation of both partners is performed concurrently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The recognition, evaluation, and treatment of infertility are stressful for most couples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/2\">",
"     2",
"    </a>",
"    ]. The clinician should not ignore the couple's emotional state, which may include depression, anger, anxiety, and marital discord. Information should be supportive and informative. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/52/22343?source=see_link\">",
"     \"Psychological stress and infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Findings on history and physical examination may suggest the cause of infertility and thus help focus the diagnostic evaluation. Components of the infertility history are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef50278 \" href=\"mobipreview.htm?19/63/20476\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important points in the history are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Duration of infertility and results of previous evaluation and therapy.",
"     </li>",
"     <li>",
"      Menstrual history (cycle length and characteristics), which helps in determining ovulatory status. For example, regular monthly cycles with molimina (breast tenderness, ovulatory pain, bloating) suggest the patient is ovulatory and characteristics such as severe dysmenorrhea suggest endometriosis.",
"     </li>",
"     <li>",
"      Medical, surgical, and gynecological history (including sexually transmitted infections, pelvic inflammatory disease, and treatment of abnormal Pap smears) to look for conditions, procedures, or medications potentially associated with infertility. At a minimum, the review of systems should determine whether the patient has symptoms of thyroid disease, galactorrhea, hirsutism, pelvic or abdominal pain, dysmenorrhea, or dyspareunia. Young women who have undergone unilateral oophorectomy generally do not have reduced fertility since young women have many primordial follicles per ovary; however, prior unilateral oophorectomy may impact fertility in older women as they may develop diminished ovarian reserve sooner than women with two ovaries [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Obstetrical history to assess for events potentially associated with subsequent infertility or adverse outcome in a future pregnancy.",
"     </li>",
"     <li>",
"      Sexual history, including sexual dysfunction and frequency of coitus. Infrequent or ineffective coitus can be an explanation for infertility.",
"     </li>",
"     <li>",
"      Family history, including family members with infertility, birth defects, genetic mutations, or mental retardation. Women with fragile X premutation may develop premature ovarian failure, while males may have learning problems, developmental delay, or autistic features.",
"     </li>",
"     <li>",
"      Personal and lifestyle history including age, occupation, exercise, stress,",
"      <span class=\"nowrap\">",
"       dieting/changes",
"      </span>",
"      in weight, smoking, and alcohol use, all of which can affect fertility.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should assess for signs of potential causes of infertility. The patient's body mass index (BMI) should be calculated and fat distribution noted, as extremes of BMI are associated with reduced fertility and abdominal obesity is associated with insulin resistance.",
"   </p>",
"   <p>",
"    Incomplete development of secondary sexual characteristics is a sign of hypogonadotropic hypogonadism. A body habitus that is short and stocky, with a squarely shaped chest, suggests Turner syndrome.",
"   </p>",
"   <p>",
"    Abnormalities of the thyroid gland, galactorrhea, or signs of androgen excess (hirsutism, acne, male pattern baldness, virilization) suggest the presence of an endocrinopathy (eg, hyper- or hypothyroidism, hyperprolactinemia, polycystic ovary syndrome, adrenal disorder).",
"   </p>",
"   <p>",
"    Tenderness or masses in the adnexae or posterior cul-de-sac (pouch of Douglas) are consistent with chronic pelvic inflammatory disease or endometriosis. Palpable tender nodules in the posterior cul-de-sac, uterosacral ligaments, or rectovaginal septum are additional signs of endometriosis.",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Vaginal/cervical",
"    </span>",
"    structural abnormalities or discharge suggest the presence of a m&uuml;llerian anomaly, infection, or cervical factor.",
"   </p>",
"   <p>",
"    Uterine enlargement, irregularity, or lack of mobility are signs of a uterine anomaly, leiomyoma, endometriosis, or pelvic adhesive disease.",
"   </p>",
"   <p>",
"    These conditions are described in detail separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/0/26633?source=see_link\">",
"       \"Clinical manifestations and diagnosis of congenital anomalies of the uterus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/51/19254?source=see_link\">",
"       \"Clinical manifestations and diagnosis of hyperprolactinemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26744?source=see_link\">",
"       \"Diagnosis of and screening for hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26520?source=see_link\">",
"       \"Diagnosis of hyperthyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/6/16490?source=see_link\">",
"       \"Clinical manifestations of polycystic ovary syndrome in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6426?source=see_link\">",
"       \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the history and physical examination, the initial diagnostic evaluation consists of:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Semen analysis to detect male factor infertility.",
"     </li>",
"     <li>",
"      Documentation of normal ovulatory function. Women with regular menses approximately every four weeks with moliminal symptoms are almost always ovulatory.",
"     </li>",
"     <li>",
"      A test to rule out tubal occlusion. We usually perform a hysterosalpingogram (HSG), but laparoscopy with chromotubation may be more appropriate in women suspected of having endometriosis.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/10/15522?source=see_link\">",
"       Indigo carmine",
"      </a>",
"      can be used for the chromotubation dye. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Role of laparoscopy'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Risk factors noted from the couple's history may indicate the need for additional testing after the initial infertility evaluation.",
"   </p>",
"   <p>",
"    Preconceptional laboratory screening may also be undertaken at this time so these results can be used for diagnostic and therapeutic counseling. Genetic screening should be offered in accordance with risk as defined by ethnicity. The components of preconception evaluation and counseling are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/25/16794?source=see_link&amp;anchor=H18#H18\">",
"     \"Preconception evaluation and counseling\", section on 'Laboratory assessment/screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Semen analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The semen analysis is the cornerstone of the assessment of the male partner of an infertile couple. In addition to the standard analysis, specialized analyses can be performed in some laboratories. The semen sample should be collected after two to seven days of abstinence and should be submitted to the laboratory within one hour of collection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is difficult to predict the likelihood of pregnancy based upon the results of semen analysis alone, as there is extensive overlap between the semen parameters of fertile and infertile men. If the semen analysis is abnormal, the clinician should review details of specimen collection and transport with the patient, repeat the test due to the marked inherent variability of semen analyses, and consider referral to a urologist or other specialist in male reproduction.",
"   </p>",
"   <p>",
"    The techniques for semen analysis and interpretation of results are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33481?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation of male infertility\", section on 'Standard semen analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Assessment of ovulatory function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of ovulatory function is a key component of the evaluation of the female partner since ovulatory dysfunction is a common cause of infertility. The treatment of women with ovulatory dysfunction is aimed at improving or inducing ovulatory function; a variety of treatment strategies is available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/5/14425?source=see_link\">",
"     \"Overview of treatment of female infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In women who do not have grossly abnormal menstrual cycles indicative of ovulatory dysfunction, laboratory assessment of ovulation should be performed. Ovulation is most easily documented by a mid-luteal phase serum progesterone level, which should be obtained approximately one week before the expected menses. For a typical 28-day cycle, the test would be obtained on day 21. A progesterone level &gt;3",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    is evidence of recent ovulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An alternative is to have the patient use an over-the-counter urinary ovulation prediction kit. These kits detect luteinizing hormone (LH) and are highly effective for predicting the timing of the LH surge that reliably indicates ovulation. Home kits have a 5 to 10 percent false positive and false negative rate. Therefore, serum confirmation can be useful in patients who are unable to detect a urinary LH surge.",
"   </p>",
"   <p>",
"    Other methods of determining ovulation, such as serial ultrasounds to follow the development and ultimately the disappearance of a follicle and endometrial biopsy to document secretory changes in the endometrium are too expensive or invasive for routine diagnostic assessment of ovulation.",
"   </p>",
"   <p>",
"    If the progesterone concentration is &lt;3",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    the patient is evaluated for causes of anovulation. The minimal work-up includes serum prolactin, thyrotropin (TSH), follicle-stimulating hormone (FSH), and assessment for polycystic ovary syndrome (PCOS). The etiology and diagnostic evaluation of anovulation are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=see_link\">",
"     \"Etiology, diagnosis, and treatment of secondary amenorrhea\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Assessment of ovarian reserve",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diminished ovarian reserve can refer to diminished oocyte quality, oocyte quantity, or reproductive potential. The identification of diminished ovarian reserve is an increasingly important component of the initial infertility evaluation as patients are presenting for diagnostic evaluation later in their reproductive lifespan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/6\">",
"     6",
"    </a>",
"    ]. However, there is no ideal test for assessing ovarian reserve. A number of screening tests are utilized, but no test is highly reliable in predicting fertility potential.",
"   </p>",
"   <p>",
"    For women over 35 years of age and younger women with risk factors for premature ovarian failure, we suggest testing ovarian reserve with a day 3 FSH level. Other tests such as the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    citrate challenge test (CCCT), antral follicle count, and anti-m&uuml;llerian hormone (AMH) level are utilized by some specialists and in special circumstances.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h4\">",
"     Day 3 FSH and CCCT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both the day 3 FSH level (where day 1 is the first day of full menstrual flow) and the CCCT, which is a provocative test for measurement of FSH, are widely used for screening ovarian reserve. The CCCT involves oral administration of 100 mg",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    citrate on cycle days 5 through 9 with measurement of day 3 and day 10 FSH levels and day 3 estradiol level.",
"   </p>",
"   <p>",
"    The basis of these tests is that women with good ovarian reserve have sufficient production of ovarian hormones from small follicles early in the menstrual cycle to maintain FSH at a low level. In contrast, women with a reduced pool of follicles and oocytes have insufficient production of ovarian hormones to provide normal inhibition of pituitary secretion of FSH, so FSH rises early in the cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Meta-analyses of nonrandomized studies concluded that basal cycle day 3 FSH and the CCCT testing perform similarly for predicting ability to achieve a clinical pregnancy in women undergoing infertility treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. With either test, a normal result is not useful in predicting fertility, but a highly abnormal result (we use FSH &gt;20",
"    <span class=\"nowrap\">",
"     mIU/mL)",
"    </span>",
"    suggests that pregnancy will not occur with treatment involving the woman's own oocytes.",
"   </p>",
"   <p>",
"    Based on these findings and the cost advantage and simplicity of the day 3 FSH, we obtain a day 3 FSH concentration and consider a value less than 10",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    suggestive of adequate ovarian reserve, and levels of 10 to 15",
"    <span class=\"nowrap\">",
"     mIU/ml",
"    </span>",
"    borderline. The upper threshold for a normal FSH concentration is laboratory dependent; cutoff values of 10 to 25",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    have been reported because of use of different FSH assay reference standards and assay methodologies.",
"   </p>",
"   <p>",
"    We also check a cycle day 3 estradiol level, although there are conflicting data as to whether it is predictive of ovarian reserve and the response to ovarian stimulation (as in in vitro fertilization [IVF]) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. We consider a value &lt;80",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    suggestive of adequate ovarian reserve, but other cut-offs are also utilized. In one prospective study of women undergoing IVF, day 3 estradiol levels &gt;80",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    resulted in higher cycle cancellation rates and lower pregnancy rates, and estradiol levels &gt;100",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    were associated with a 0 percent pregnancy rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Elevated basal estradiol levels are due to advanced premature follicle recruitment that occurs in women with poor ovarian reserve. High estradiol levels can inhibit pituitary FSH production and thus mask one of the signs of decreased ovarian reserve in perimenopausal women. Thus, measurement of both FSH and estradiol levels helps to avoid false-negative FSH testing.",
"   </p>",
"   <p>",
"    If CCCT is performed, we consider FSH less than 15",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    on both day 3 and day 10 suggestive of adequate ovarian reserve; an elevated FSH level on either day 3 or day 10 suggests decreased ovarian reserve. Estradiol can be measured on day 3, but a cycle day 10 estradiol is not part of the standard CCCT as it reflects the magnitude of the ovarian follicular response to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    100 mg daily for five days, not ovarian reserve.",
"   </p>",
"   <p>",
"    If the day 3 FSH or CCCT is abnormal, the patient should be referred to a reproductive endocrinologist to discuss further diagnostic and treatment options. These options, which also depend on the results of other diagnostic tests, the age of the female partner, and other factors, may include aggressive ovulation induction, IVF, or use of donor oocytes. However, patients with markedly diminished ovarian reserve rarely conceive without the use of donor eggs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h4\">",
"     Antral follicle count (AFC)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound examination can be used to determine the number of antral follicles (defined as follicles measuring 2 to 10 mm in diameter). On transvaginal ultrasound, a low AFC ranging from 4 to 10 antral follicles between days two and four of a regular menstrual cycle suggests poor ovarian reserve.&nbsp;AFC thresholds will vary by center and should be prospectively tested within a center to be most useful as a predictive tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]. Most clinicians perform an AFC during the early follicular phase, although a retrospective cohort study showed no difference in the predictive value of AFC for poor ovarian response when measured at different phases of the menstrual cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/17\">",
"     17",
"    </a>",
"    ]. Although AFC is a good predictor of ovarian reserve and response, it is less predictive of oocyte quality, the ability to conceive with IVF, and pregnancy outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h4\">",
"     Anti-m&uuml;llerian hormone (AMH)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anti-m&uuml;llerian hormone (AMH) is a member of the TGF-beta family and is expressed by the small (&lt;8 mm) preantral and early antral follicles. The AMH level reflects the size of the primordial follicle pool. In adult women, AMH levels gradually decline as the primordial follicle pool declines with age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/19\">",
"     19",
"    </a>",
"    ]; AMH is undetectable at menopause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The AMH level appears to be an early, reliable, direct indicator of declining ovarian function, however, there is no consensus on the appropriate threshold value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/10,20-26\">",
"     10,20-26",
"    </a>",
"    ]. A serum AMH level above 0.5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    is consistent with good ovarian reserve, while lower levels suggest the presence of a depleted ovarian follicle pool. Levels less than 0.15",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    suggest the patient will have a poor response to IVF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/10,21\">",
"     10,21",
"    </a>",
"    ]. Measurement of AMH may play an especially useful role in identifying reduced ovarian follicle pool in certain types of patients, such as cancer patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    AMH can be measured anytime during the menstrual cycle and typically demonstrates minimal intercycle and intracycle variability since the growth of small preantral follicles that express it is continuous, not cyclical. Reliable AMH kits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/27\">",
"     27",
"    </a>",
"    ] are readily available from multiple vendors and AMH measurements can be obtained from large clinical reference laboratories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/28,29\">",
"     28,29",
"    </a>",
"    ], but most insurers in the United States do not reimburse for the test. AMH level is being used to manage patients in Europe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Assessment of fallopian tube patency",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform HSG as the first-line test for evaluation of tubal patency because of its therapeutic, as well as diagnostic, benefits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/31\">",
"     31",
"    </a>",
"    ]. Non- or minimally invasive alternatives to HSG for investigation of tubal subfertility include chlamydia antibody testing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hysterosalpingo-contrast sonography (HyCoSy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When the diagnosis is in doubt, more invasive tests can be used to confirm the diagnosis, and provide an opportunity for concurrent therapeutic intervention. These tests include laparoscopy with chromotubation and",
"    <span class=\"nowrap\">",
"     fluoroscopic/hysteroscopic",
"    </span>",
"    selective tubal cannulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h4\">",
"     Hysterosalpingogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;We obtain a HSG to look for tubal occlusion in all patients, unless laparoscopy is planned [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Either water or lipid soluble contrast media can be used. HSG also provides information about the uterine cavity. Women with abnormalities on HSG should be referred to a reproductive endocrinologist to discuss treatment options. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/37/24150?source=see_link\">",
"     \"Hysterosalpingography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HSG is not useful for detecting peritubal adhesions or endometriosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/33\">",
"     33",
"    </a>",
"    ]. We perform diagnostic laparoscopy and chromotubation in women suspected of having endometriosis or pelvic adhesions related to a previous pelvic infection or surgery. Ablation of implants and lysis of adhesions, when indicated, can be performed at the same procedure (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Role of laparoscopy'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    A meta-analysis of 20 studies involving 4179 patients compared HSG and laparoscopy with chromotubation (the gold standard); the calculated sensitivity and specificity for diagnosis of tubal patency were only 65 and 83 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/33\">",
"     33",
"    </a>",
"    ]. However, when subgroups of women undergoing HSG were analyzed, HSG appeared to have very high specificity and sensitivity for diagnosing distal tubal occlusion or major distal tubal adhesions, but much lower specificity for diagnosing proximal tubal occlusion.",
"   </p>",
"   <p>",
"    Proximal tubal occlusion on HSG often represents testing artifact due to tubal spasm or poor catheter positioning leading to unilateral tubal perfusion. Given these deficiencies, findings of proximal tubal occlusion on HSG could be confirmed by a secondary test such as a repeat HSG, fluoroscopic or hysteroscopic selective tubal perfusion, or laparoscopic chromotubation if definitive diagnosis will influence further management.",
"   </p>",
"   <p>",
"    Diagnostic HSG also appears to have therapeutic effects. A systematic review of 12 randomized trials found that pregnancy rates were significantly higher in subfertile women who underwent tubal flushing with oil soluble media than in those who did not undergo HSG (OR 3.30, 95% CI 2.00-5.43), and that pregnancy rates were similar whether oil or water soluble media were used (OR 1.21, 95%CI 0.95-1.54) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h4\">",
"     Chlamydia antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chlamydia trachomatis IgG antibody testing is a simple, inexpensive, noninvasive test with some evidence supporting its use as a method for predicting the presence of tubal disease. Studies suggest that antibodies to chlamydia are more predictive of infertility than an abnormal HSG or a history of previous use of a copper IUD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/35-40\">",
"     35-40",
"    </a>",
"    ]. Multiple tests are available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/41\">",
"     41",
"    </a>",
"    ], but not widely utilized given only limited data supporting their use. A cost-effective approach might be to screen women at low risk of tubal disease with chlamydia antibodies. A negative test is associated with &lt;15 percent likelihood of tubal pathology and thus does not require further assessment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/42\">",
"     42",
"    </a>",
"    ]. False positives are due to cross reactivity withC. pneumoniae, do not distinguish between remote and persistent infection, and do not indicate whether infection resulted in tubal damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/42\">",
"     42",
"    </a>",
"    ]; therefore, an HSG is performed if the test results are positive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/43\">",
"     43",
"    </a>",
"    ]. Women at high risk of tubal disease would be screened by HSG primarily.",
"   </p>",
"   <p>",
"    In a study correlating results of five chlamydia antibody tests to laparoscopy findings in 315 subfertile women, the diagnostic performance of micro-immunofluorescence testing was superior to ELISA testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/44\">",
"     44",
"    </a>",
"    ]. However, there was significant cross-reactivity with C. pneumoniae antibodies for all tests except the pELISA Medac. Thus, positive test results from other modalities should be confirmed with this ELISA. In this study, a positive pELISA Medac had sensitivity and specificity of 55 and 87 percent, respectively, for tubal pathology at laparoscopy.",
"   </p>",
"   <p>",
"    Chlamydia antibody testing can be used to screen women with an allergy to shellfish or iodinated contrast agents who cannot undergo an HSG. In women without risk factors for tubal disease, a negative test does not require further tubal assessment. If the test is positive, a sonohysterogram may be performed; presence of fluid in the cul-de-sac after intrauterine infusion of saline indicates patency of at least one tube.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22889999\">",
"    <span class=\"h4\">",
"     Hysterosalpingo-contrast sonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hysterosalpingo-contrast sonography (HyCoSy) uses ultrasound to view the uterus, tubes, and adnexa before and after transcervical injection of echogenic contrast media. It is a safe, well tolerated, quick and easy method for obtaining information on tubal status, the uterine cavity, the ovaries, and the myometrium using conventional ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/45\">",
"     45",
"    </a>",
"    ]. In comparative studies, performance has compared favorably with HSG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/46-50\">",
"     46-50",
"    </a>",
"    ]. A meta-analysis involving over 1000 women who underwent diagnostic imaging because of tubal-related infertility found HyCoSy and HSG were 83 percent concordant for detecting tubal pathology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/51\">",
"     51",
"    </a>",
"    ]. Using laparoscopy with chromotubation as the reference standard, HyCoSy showed false occlusion in 85 tubes (10.3 percent) and false patency in 55 tubes (6.7 percent); HSG showed false occlusion in 19 tubes (12.5 percent) and false patency in 17 tubes (11.2 percent). Tubal spasm and tubal fistula, as well as operator error, accounted for the misdiagnoses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Assessment of the uterine cavity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to assessment of tubal patency, HSG may identify developmental or acquired abnormalities of the uterine cavity with potential effects on fertility, such as submucous fibroids, a T-shaped cavity (associated with DES exposure), polyps, synechiae, and congenital m&uuml;llerian anomalies (although HSG alone cannot reliably distinguish between a uterine septum or bicornuate uterus). Abnormalities found on HSG generally require further evaluation by other imaging modalities (ultrasonography or magnetic resonance imaging), hysteroscopy, or laparoscopy and referral to a reproductive endocrinologist.",
"   </p>",
"   <p>",
"    Ultrasonography is a useful test for evaluation of suspected leiomyomata, while saline infusion sonohysterography is the best imaging modality for detection of submucosal leiomyomas and is much better than routine ultrasonography for diagnosis of intrauterine adhesions, polyps, and congenital uterine anomalies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/52\">",
"     52",
"    </a>",
"    ]. As discussed above, HyCoSy is a simple, time-efficient, and effective method for evaluation of tubal patency, the uterine cavity, and the myometrium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hysteroscopy is the definitive method for evaluation of abnormalities of the endometrial cavity, and also offers the opportunity for treatment at time of diagnosis. In patients undergoing laparoscopy, performing hysteroscopy at the same time and omitting HSG is efficient.",
"   </p>",
"   <p>",
"    Evaluation of uterine anomalies depends on the anomaly.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=see_link\">",
"       \"Overview of hysteroscopy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/55/40823?source=see_link\">",
"       \"Saline infusion sonohysterography\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/0/26633?source=see_link\">",
"       \"Clinical manifestations and diagnosis of congenital anomalies of the uterus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32601?source=see_link\">",
"       \"Hysteroscopic myomectomy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/31/26101?source=see_link\">",
"       \"Intrauterine adhesions\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ROLE OF LAPAROSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of laparoscopy in the evaluation of infertility is controversial. Laparoscopy is invasive and expensive. Findings at laparoscopy usually do not alter the initial treatment of the infertile couple when the initial infertility evaluation is normal or when it shows severe male factor infertility. Couples with a normal infertility evaluation (ie, unexplained infertility) typically undergo a trial of ovarian stimulation with or without intrauterine insemination and many will conceive without further intervention. Couples with tubal or male factor infertility are typically offered IVF as one of their treatment options. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/57/25496?source=see_link\">",
"     \"Unexplained infertility\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/56/37770?source=see_link\">",
"     \"In vitro fertilization\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No randomized trials have assessed the cost effectiveness and timing of diagnostic laparoscopy prior to ovulation induction in couples with unexplained infertility. Laparoscopy is indicated in women in whom endometriosis or pelvic",
"    <span class=\"nowrap\">",
"     adhesions/tubal",
"    </span>",
"    disease is suspected based on physical examination, HSG, or history (eg, current dysmenorrhea, pelvic pain, or deep dyspareunia; previous complicated appendicitis, pelvic infection, pelvic surgery, or ectopic pregnancy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. When we perform laparoscopy, we also perform chromotubation to assess tubal patency and hysteroscopy to evaluate the uterine cavity. For this reason, if laparoscopy is planned, then HSG can be omitted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The advantage of performing laparoscopy early in the evaluation of women suspected of having endometriosis or pelvic adhesions is that surgical therapy can be initiated, while avoiding potentially ineffective or unnecessary empiric medical treatment for ovulation induction. Endometriosis, if identified, can be",
"    <span class=\"nowrap\">",
"     excised/ablated",
"    </span>",
"    at the time of the diagnostic procedure and pelvic adhesions can be lysed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/15/38136?source=see_link\">",
"     \"Pathogenesis and treatment of infertility in women with endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of laparoscopy to treat infertility is covered in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/18/9513?source=see_link\">",
"     \"Reproductive surgery for female infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TESTS OF LIMITED CLINICAL UTILITY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Postcoital test",
"    </span>",
"    &nbsp;&mdash;&nbsp;In agreement with other experts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/1,57\">",
"     1,57",
"    </a>",
"    ], we do not recommend postcoital testing.",
"   </p>",
"   <p>",
"    The postcoital test has poor diagnostic potential and predictive value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/58,59\">",
"     58,59",
"    </a>",
"    ] that is due, in part, to the lack of consensus on a normal versus abnormal test result and to low inter- and intraobserver reproducibility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/60\">",
"     60",
"    </a>",
"    ]. In addition, interventions designed to improve cervical factor infertility have not been effective, while widely used infertility therapies, such as intrauterine insemination and IVF bypass the cervix so improving cervical factors becomes irrelevant. Importantly, a randomized trial that compared the outcome of infertility investigations with and without the postcoital test showed no difference in pregnancy rates at 24 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/61\">",
"     61",
"    </a>",
"    ]. Thus, incorporation of the postcoital test in standard infertility evaluations increases the number of tests and treatments, but has no effect on the pregnancy rate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Endometrial biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial biopsy has been performed for two reasons: (1) to document a secretory endometrium, which is indirect evidence that ovulation has occurred, and (2) to evaluate whether the maturity of the secretory endometrium is in phase (ie, consistent with menstrual cycle date) or out of phase (ie, luteal phase defect). It is not a good test for either indication because it is invasive, expensive, uncomfortable, unnecessary for evaluation of ovulation, and ineffective for assessment of endometrial receptivity (ie, the ability of the endometrium to allow the blastocyst to attach, invade, and implant).",
"   </p>",
"   <p>",
"    As discussed above, ovulation is optimally assessed using serum progesterone level &gt;3",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    obtained in the late luteal phase (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Assessment of ovulatory function'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Although endometrial receptivity during the implantation window is crucial for achieving pregnancy, histological assessment of endometrial response has a poor correlation with fertility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/62-66\">",
"     62-66",
"    </a>",
"    ]. For example, when repeated endometrial biopsies are performed in normal fertile women, half will have a single out-of-phase biopsy (using two-day or greater lag criteria) and over one-quarter will have sequential out-of-phase biopsies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Moreover, in one study of 619 women with regular menstrual cycles, a biopsy that was out-of-phase by greater than two days was actually more common in fertile women than in infertile women (at day 21 to 22: 49 versus 43 percent; at day 26 to 27: 35 versus 23 percent).",
"   </p>",
"   <p>",
"    Thus, it appears that histological dating does not discriminate fertile from infertile couples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. As the treatment of luteal phase defect does not improve pregnancy outcome in infertile women, luteal phase evaluation by histological dating of the endometrium is not worthwhile.",
"   </p>",
"   <p>",
"    The American Society of Reproductive Medicine (ASRM) affirmed the lack of benefit of the endometrial biopsy in the evaluation of the infertile female and does not recommend use of this test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endometrial biopsy is appropriate when endometrial pathology is strongly suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Basal body temperature records",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basal body temperature charts are the least expensive method for detecting ovulation, but interpretation of the charts can be difficult and subject to wide interobserver variation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. We prefer serum testing for assessment of ovulatory status in women with irregular cycles (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Assessment of ovulatory function'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Progesterone released from the corpus luteum at the time of ovulation has potent effects on the hypothalamus, one of which is to increase body temperature. As a result, daily temperature monitoring can be used to document progesterone production and, therefore, ovulation. The woman takes her temperature by putting the thermometer under her tongue every morning while she is still in the basal state (ie, before she gets out of bed, uses the bathroom, or has anything to eat or drink) and records the temperature on a chart. Although there is an expected amount of daily variability, an approximately 0.5&ordm;F rise in body temperature can be detected in the luteal phase of the menstrual cycle compared with the follicular phase. In a normal cycle, the temperature rise begins one or two days after the LH surge and persists for at least 10 days. Thus, temperature changes are sufficient to retrospectively identify ovulation, but they occur too late to be useful for timing intercourse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Zona-free hamster oocyte penetration test",
"    </span>",
"    &nbsp;&mdash;&nbsp;This test is also known as the sperm penetration assay. Conflicting literature exists on whether the hamster oocyte test predicts human oocyte fertilization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. The utility of test results depends, in part, on the experience of the laboratory performing the assay. We do not order this test since the results would not influence our clinical management. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33481?source=see_link&amp;anchor=H25#H25\">",
"     \"Evaluation of male infertility\", section on 'Zona-free hamster oocyte penetration test'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Mycoplasma cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not suggest obtaining routine Ureaplasma urealyticum and Mycoplasma hominis cultures given that there is minimal evidence for a role of these organisms in female infertility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Testing for antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine testing for antiphospholipid, antisperm, antinuclear, and antithyroid antibodies is not supported by existing data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/74\">",
"     74",
"    </a>",
"    ]. Although an association between antiphospholipid antibodies and recurrent pregnancy loss has been established, the other autoimmune factors remain under investigation as markers of fertility treatment failure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/2/41000?source=see_link\">",
"     \"Obstetrical manifestations of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Karyotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a general consensus to counsel and offer to karyotype the male partner if there is severe oligospermia, as these men are at higher risk of karyotypic abnormalities. Separate testing for Y chromosome microdeletions may also be offered. We suggest karyotyping women with very early premature menopause (prior to age 40) and both partners if there have been recurrent pregnancy losses. In most other circumstances, karyotyping is not indicated as part of the initial evaluation because of the low incidence of abnormalities in women with unexplained infertility, endometriosis, or tubal factor infertility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/75\">",
"     75",
"    </a>",
"    ]. Karyotype may be useful in patients with these conditions who have failed initial treatment approaches and plan to undergo IVF, although the cost-effectiveness of universal karyotype screening prior to IVF has not been established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/61/40921/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/16/11523?source=see_link\">",
"       \"Patient information: Infertility in women (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/25/6547?source=see_link\">",
"       \"Patient information: Infertility in couples (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/4/34883?source=see_link\">",
"       \"Patient information: Ovulation induction with clomiphene (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/42/22180?source=see_link\">",
"       \"Patient information: Evaluation of the infertile couple (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest that an infertility evaluation be offered to couples who have not been able to conceive after 12 months of unprotected and frequent intercourse (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Earlier evaluation (eg, after six months) is indicated in some couples, such as those in whom the female partner is over 35 years of age or has a history of",
"      <span class=\"nowrap\">",
"       oligo/amenorrhea,",
"      </span>",
"      known or suspected tubal disease or endometriosis, a history of chemotherapy or radiation therapy, and those in whom the male partner is known to be subfertile. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Initial approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The history and physical examination are directed at identifying signs and symptoms suggestive of the etiology of the infertility. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The basic infertility evaluation of all couples consists of:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Semen analysis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Semen analysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assessment of ovulatory status by history or laboratory testing. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Assessment of ovulatory function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Determination of tubal patency and presence or absence of abnormalities of the uterine cavity, usually by hysterosalpingogram. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Assessment of fallopian tube patency'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Assessment of the uterine cavity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ovarian reserve is assessed with day 3 follicle-stimulating hormone (FSH) and estradiol levels in women over 35 years of age and younger women with risk factors for premature ovarian failure. Other tests such as the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/22/23909?source=see_link\">",
"       clomiphene",
"      </a>",
"      citrate challenge test (CCCT), antral follicle count, and anti-m&uuml;llerian hormone (AMH) level are utilized in special circumstances. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Assessment of ovarian reserve'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnostic laparoscopy is indicated for women with suspected endometriosis or pelvic adhesions. When we perform laparoscopy, we also perform chromotubation to assess tubal patency and hysteroscopy to evaluate the uterine cavity. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Role of laparoscopy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/1\">",
"      Practice Committee of American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril 2012; 98:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/2\">",
"      Cousineau TM, Domar AD. Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol 2007; 21:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/3\">",
"      Lass A. The fertility potential of women with a single ovary. Hum Reprod Update 1999; 5:546.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization, WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th edition. Cambridge University Press, Cambridge, UK, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/5\">",
"      Wathen NC, Perry L, Lilford RJ, Chard T. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) 1984; 288:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/6\">",
"      Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 2012; 98:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/7\">",
"      Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 2004; 19:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/8\">",
"      Jain T, Soules MR, Collins JA. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 2004; 82:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/9\">",
"      Hendriks DJ, Mol BW, Bancsi LF, et al. The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization: a systematic review. Fertil Steril 2006; 86:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/10\">",
"      Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006; 12:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/11\">",
"      Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995; 64:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/12\">",
"      Smotrich DB, Widra EA, Gindoff PR, et al. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995; 64:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/13\">",
"      Tomas C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 1997; 12:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/14\">",
"      Chang MY, Chiang CH, Hsieh TT, et al. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998; 69:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/15\">",
"      Broekmans FJ, de Ziegler D, Howles CM, et al. The antral follicle count: practical recommendations for better standardization. Fertil Steril 2010; 94:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/16\">",
"      Jayaprakasan K, Chan Y, Islam R, et al. Prediction of in&nbsp;vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women. Fertil Steril 2012; 98:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/17\">",
"      Rombauts L, Onwude JL, Chew HW, Vollenhoven BJ. The predictive value of antral follicle count remains unchanged across the menstrual cycle. Fertil Steril 2011; 96:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/18\">",
"      Hsu A, Arny M, Knee AB, et al. Antral follicle count in clinical practice: analyzing clinical relevance. Fertil Steril 2011; 95:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/19\">",
"      Seifer DB, Baker VL, Leader B. Age-specific serum anti-M&uuml;llerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril 2011; 95:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/20\">",
"      de Vet A, Laven JS, de Jong FH, et al. Antim&uuml;llerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002; 77:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/21\">",
"      Gnoth C, Schuring AN, Friol K, et al. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod 2008; 23:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/22\">",
"      Lutchman Singh K, Muttukrishna S, Stein RC, et al. Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 2007; 96:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/23\">",
"      van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005; 83:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/24\">",
"      Steiner AZ, Herring AH, Kesner JS, et al. Antim&uuml;llerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol 2011; 117:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/25\">",
"      Almog B, Shehata F, Suissa S, et al. Age-related normograms of serum antim&uuml;llerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril 2011; 95:2359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/26\">",
"      Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod 2011; 26:1905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/27\">",
"      Dorgan JF, Spittle CS, Egleston BL, et al. Assay reproducibility and within-person variation of M&uuml;llerian inhibiting substance. Fertil Steril 2010; 94:301.",
"     </a>",
"    </li>",
"    <li>",
"     Fleming, R, Deshpande, N, Traynor, I, Yates, RW. Dynamics of FSH-induced follicular growth in subfertile women. Hum Reprod 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/29\">",
"      Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-M&uuml;llerian hormone: a new marker for ovarian function. Reproduction 2006; 131:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/30\">",
"      Johnson NP, Bagrie EM, Coomarasamy A, et al. Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy. BJOG 2006; 113:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/31\">",
"      Luttjeboer F, Harada T, Hughes E, et al. Tubal flushing for subfertility. Cochrane Database Syst Rev 2007; :CD003718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/32\">",
"      Lim CP, Hasafa Z, Bhattacharya S, Maheshwari A. Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertility in the modern subfertility workup? Hum Reprod 2011; 26:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/33\">",
"      Swart P, Mol BW, van der Veen F, et al. The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril 1995; 64:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/34\">",
"      Papaioannou S, Bourdrez P, Varma R, et al. Tubal evaluation in the investigation of subfertility: a structured comparison of tests. BJOG 2004; 111:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/35\">",
"      Thomas K, Coughlin L, Mannion PT, Haddad NG. The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations. Hum Reprod 2000; 15:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/36\">",
"      Dabekausen YA, Evers JL, Land JA, Stals FS. Chlamydia trachomatis antibody testing is more accurate than hysterosalpingography in predicting tubal factor infertility. Fertil Steril 1994; 61:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/37\">",
"      Hubacher D, Lara-Ricalde R, Taylor DJ, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001; 345:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/38\">",
"      Veenemans LM, van der Linden PJ. The value of Chlamydia trachomatis antibody testing in predicting tubal factor infertility. Hum Reprod 2002; 17:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/39\">",
"      Mol BW, Dijkman B, Wertheim P, et al. The accuracy of serum chlamydial antibodies in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril 1997; 67:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/40\">",
"      Rodgers AK, Budrys NM, Gong S, et al. Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility. Fertil Steril 2011; 96:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/41\">",
"      Fiddelers AA, Land JA, Voss G, et al. Cost-effectiveness of Chlamydia antibody tests in subfertile women. Hum Reprod 2005; 20:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/42\">",
"      den Hartog JE, Morr&eacute; SA, Land JA. Chlamydia trachomatis-associated tubal factor subfertility: Immunogenetic aspects and serological screening. Hum Reprod Update 2006; 12:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/43\">",
"      Mol BW, Collins JA, Van Der Veen F, Bossuyt PM. Cost-effectiveness of hysterosalpingography, laparoscopy, and Chlamydia antibody testing in subfertile couples. Fertil Steril 2001; 75:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/44\">",
"      Land JA, Gijsen AP, Kessels AG, et al. Performance of five serological chlamydia antibody tests in subfertile women. Hum Reprod 2003; 18:2621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/45\">",
"      Saunders RD, Shwayder JM, Nakajima ST. Current methods of tubal patency assessment. Fertil Steril 2011; 95:2171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/46\">",
"      Luciano DE, Exacoustos C, Johns DA, Luciano AA. Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients? Am J Obstet Gynecol 2011; 204:79.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/47\">",
"      Hamed HO, Shahin AY, Elsamman AM. Hysterosalpingo-contrast sonography versus radiographic hysterosalpingography in the evaluation of tubal patency. Int J Gynaecol Obstet 2009; 105:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/48\">",
"      Ahinko-Hakamaa KM, Huhtala H, Tinkanen H. Confirmation of tubal patency in hysterosalpingo-contrast sonography by transvaginal hydrolaparoscopy. Acta Obstet Gynecol Scand 2009; 88:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/49\">",
"      Lanzani C, Savasi V, Leone FP, et al. Two-dimensional HyCoSy with contrast tuned imaging technology and a second-generation contrast media for the assessment of tubal patency in an infertility program. Fertil Steril 2009; 92:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/50\">",
"      Shahid N, Ahluwalia A, Briggs S, Gupta S. An audit of patients investigated by Hysterosalpingo-Contrast-Sonography (HyCoSy) for infertility. J Obstet Gynaecol 2005; 25:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/51\">",
"      Holz K, Becker R, Sch&uuml;rmann R. Ultrasound in the investigation of tubal patency. A meta-analysis of three comparative studies of Echovist-200 including 1007 women. Zentralbl Gynakol 1997; 119:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/52\">",
"      Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril 2000; 73:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/53\">",
"      Balasch J. Investigation of the infertile couple: investigation of the infertile couple in the era of assisted reproductive technology: a time for reappraisal. Hum Reprod 2000; 15:2251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/54\">",
"      Smith S, Pfeifer SM, Collins JA. Diagnosis and management of female infertility. JAMA 2003; 290:1767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/55\">",
"      Luttjeboer FY, Verhoeve HR, van Dessel HJ, et al. The value of medical history taking as risk indicator for tuboperitoneal pathology: a systematic review. BJOG 2009; 116:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/56\">",
"      Perquin DA, D&ouml;rr PJ, de Craen AJ, Helmerhorst FM. Routine use of hysterosalpingography prior to laparoscopy in the fertility workup: a multicentre randomized controlled trial. Hum Reprod 2006; 21:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/57\">",
"      Oei SG, Helmerhorst FM, Keirse MJ. When is the post-coital test normal? A critical appraisal. Hum Reprod 1995; 10:1711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/58\">",
"      Griffith CS, Grimes DA. The validity of the postcoital test. Am J Obstet Gynecol 1990; 162:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/59\">",
"      Collins JA, So Y, Wilson EH, et al. The postcoital test as a predictor of pregnancy among 355 infertile couples. Fertil Steril 1984; 41:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/60\">",
"      Glatstein IZ, Best CL, Palumbo A, et al. The reproducibility of the postcoital test: a prospective study. Obstet Gynecol 1995; 85:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/61\">",
"      Oei SG, Helmerhorst FM, Bloemenkamp KW, et al. Effectiveness of the postcoital test: randomised controlled trial. BMJ 1998; 317:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/62\">",
"      Balasch J, F&aacute;bregues F, Creus M, Vanrell JA. The usefulness of endometrial biopsy for luteal phase evaluation in infertility. Hum Reprod 1992; 7:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/63\">",
"      Edwards RG. Physiological and molecular aspects of human implantation. Hum Reprod 1995; 10 Suppl 2:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/64\">",
"      Creus M, Balasch J, Ordi J, et al. Integrin expression in normal and out-of-phase endometria. Hum Reprod 1998; 13:3460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/65\">",
"      Giudice LC. Potential biochemical markers of uterine receptivity. Hum Reprod 1999; 14 Suppl 2:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/66\">",
"      Murray MJ, Meyer WR, Zaino RJ, et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril 2004; 81:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/67\">",
"      Davis OK, Berkeley AS, Naus GJ, et al. The incidence of luteal phase defect in normal, fertile women, determined by serial endometrial biopsies. Fertil Steril 1989; 51:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/68\">",
"      Coutifaris C, Myers ER, Guzick DS, et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004; 82:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/69\">",
"      Bauman JE. Basal body temperature: unreliable method of ovulation detection. Fertil Steril 1981; 36:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/70\">",
"      Kambic R, Gray RH. Interobserver variation in estimation of day of conception intercourse using selected natural family planning charts. Fertil Steril 1989; 51:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/71\">",
"      Shibahara H, Mitsuo M, Inoue M, et al. Relationship between human in-vitro fertilization and intracytoplasmic sperm injection and the zona-free hamster egg penetration test. Hum Reprod 1998; 13:1928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/72\">",
"      Zainul Rashid MR, Fishel SB, Thornton S, et al. The predictive value of the zona-free hamster egg penetration test in relation to in-vitro fertilization at various insemination concentrations. Hum Reprod 1998; 13:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/73\">",
"      Gump DW, Gibson M, Ashikaga T. Lack of association between genital mycoplasmas and infertility. N Engl J Med 1984; 310:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/74\">",
"      Kallen CB, Arici A. Immune testing in fertility practice: truth or deception? Curr Opin Obstet Gynecol 2003; 15:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/75\">",
"      Papanikolaou EG, Vernaeve V, Kolibianakis E, et al. Is chromosome analysis mandatory in the initial investigation of normovulatory women seeking infertility treatment? Hum Reprod 2005; 20:2899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/61/40921/abstract/76\">",
"      Riccaboni A, Lalatta F, Caliari I, et al. Genetic screening in 2,710 infertile candidate couples for assisted reproductive techniques: results of application of Italian guidelines for the appropriate use of genetic tests. Fertil Steril 2008; 89:800.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5445 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.97.94.19-A044F949FA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40921=[""].join("\n");
var outline_f39_61_40921=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INITIAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Semen analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Assessment of ovulatory function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Assessment of ovarian reserve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Day 3 FSH and CCCT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Antral follicle count (AFC)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Anti-m&uuml;llerian hormone (AMH)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Assessment of fallopian tube patency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hysterosalpingogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Chlamydia antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H22889999\">",
"      Hysterosalpingo-contrast sonography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Assessment of the uterine cavity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ROLE OF LAPAROSCOPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TESTS OF LIMITED CLINICAL UTILITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Postcoital test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Endometrial biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Basal body temperature records",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Zona-free hamster oocyte penetration test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Mycoplasma cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Testing for antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Karyotype",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5445\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5445|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/63/20476\" title=\"table 1\">",
"      Infertility evaluation - history",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/18/3367?source=related_link\">",
"      Causes of female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/54/11114?source=related_link\">",
"      Causes of male infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33449?source=related_link\">",
"      Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/0/26633?source=related_link\">",
"      Clinical manifestations and diagnosis of congenital anomalies of the uterus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/51/19254?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/6/16490?source=related_link\">",
"      Clinical manifestations of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26744?source=related_link\">",
"      Diagnosis of and screening for hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26520?source=related_link\">",
"      Diagnosis of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=related_link\">",
"      Etiology, diagnosis, and treatment of secondary amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33481?source=related_link\">",
"      Evaluation of male infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/37/24150?source=related_link\">",
"      Hysterosalpingography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32601?source=related_link\">",
"      Hysteroscopic myomectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/56/37770?source=related_link\">",
"      In vitro fertilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/31/26101?source=related_link\">",
"      Intrauterine adhesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/2/41000?source=related_link\">",
"      Obstetrical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=related_link\">",
"      Overview of hysteroscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/56/17287?source=related_link\">",
"      Overview of infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/5/14425?source=related_link\">",
"      Overview of treatment of female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/15/38136?source=related_link\">",
"      Pathogenesis and treatment of infertility in women with endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/42/22180?source=related_link\">",
"      Patient information: Evaluation of the infertile couple (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/25/6547?source=related_link\">",
"      Patient information: Infertility in couples (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/16/11523?source=related_link\">",
"      Patient information: Infertility in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/4/34883?source=related_link\">",
"      Patient information: Ovulation induction with clomiphene (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/25/16794?source=related_link\">",
"      Preconception evaluation and counseling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/52/22343?source=related_link\">",
"      Psychological stress and infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/18/9513?source=related_link\">",
"      Reproductive surgery for female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/55/40823?source=related_link\">",
"      Saline infusion sonohysterography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3610?source=related_link\">",
"      Treatment of male infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/57/25496?source=related_link\">",
"      Unexplained infertility",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_61_40922="Transplant glomerulopathy Light";
var content_f39_61_40922=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58239%7ENEPH%2F79914&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58239%7ENEPH%2F79914&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transplant glomerulopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of transplant glomerulopathy shows a membranoproliferative pattern with capillary wall thickening and a double-contour appearance due to mesangial interposition (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transplant glomerulopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of transplant glomerulopathy reveals marked narrowing of the vascular lumen due to widening of the subenthothelial space both by mesangial cell processes (arrow) and by amorphous, electron-lucent material.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Electron micrograph of a normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of a normal glomerular capillary loop showing the fenestrated endothelial cell (Endo), the glomerular basement membrane (GBM), and the epithelial cells with its interdigitating foot processes (arrow). The GBM is thin, and no electron dense deposits are present. Two normal platelets are seen in the capillary lumen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40922=[""].join("\n");
var outline_f39_61_40922=null;
var title_f39_61_40923="Low IgG subclass levels in different populations";
var content_f39_61_40923=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Frequency of decreased IgG subclass concentrations in different populations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Sample population",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Number",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        IgG1",
"       </td>",
"       <td class=\"subtitle2\">",
"        IgG2",
"       </td>",
"       <td class=\"subtitle2\">",
"        IgG3",
"       </td>",
"       <td class=\"subtitle2\">",
"        IgG4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Healthy children",
"       </td>",
"       <td class=\"centered\">",
"        3854",
"       </td>",
"       <td class=\"centered\">",
"        4.9",
"       </td>",
"       <td class=\"centered\">",
"        19.4",
"       </td>",
"       <td class=\"centered\">",
"        6.3",
"       </td>",
"       <td class=\"centered\">",
"        0.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Healthy adults",
"       </td>",
"       <td class=\"centered\">",
"        162",
"       </td>",
"       <td class=\"centered\">",
"        8",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adults with suspected antibody defects",
"       </td>",
"       <td class=\"centered\">",
"        1175",
"       </td>",
"       <td class=\"centered\">",
"        28",
"       </td>",
"       <td class=\"centered\">",
"        17",
"       </td>",
"       <td class=\"centered\">",
"        13",
"       </td>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Data from different populations showing the percentage of individuals with low serum levels of specific IgG subclasses.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Meulenbroek AJ, Zeijlemaker WP. Human IgG subclasses: Useful diagnostic markers for immunocompetence, 2nd edition, CLB, Amsterdam, The Netherlands 2000. Copyright &copy; 2000 Sanquin Blood Supply Foundation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40923=[""].join("\n");
var outline_f39_61_40923=null;
var title_f39_61_40924="Amine alkaloid sympath herbs B";
var content_f39_61_40924=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F63729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F63729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Herbal ingredients with amines, alkaloids or sympathomimetic action: part B",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Golden seal",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gravel root",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hawthorn",
"       </td>",
"       <td>",
"        Tyramine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Horehound, white",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydrocotyle",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ispaghula",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jamaica dogwood",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liferoot",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lobelia",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mat&eacute;",
"       </td>",
"       <td>",
"        Alkaloids, amines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mistletoe",
"       </td>",
"       <td>",
"        Histamine release",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motherwort",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nettle",
"       </td>",
"       <td>",
"        Choline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parsley",
"       </td>",
"       <td>",
"        Myristicin, sympathomimetic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Passionflower",
"       </td>",
"       <td>",
"        Alkaloids, MAOI activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plantain",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pleurisy root",
"       </td>",
"       <td>",
"        Sympathomimetic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pokeroot",
"       </td>",
"       <td>",
"        Betalains",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prickly ash, northern and southern",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quassia",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sassafras",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shepherd's purse",
"       </td>",
"       <td>",
"        Choline, tyramine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skunk cabbage",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        St. John's Wort",
"       </td>",
"       <td>",
"        MAOI activity, in vitro",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stone root",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Valerian",
"       </td>",
"       <td>",
"        Alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vervain",
"       </td>",
"       <td>",
"        Sympathomimetic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yarrow",
"       </td>",
"       <td>",
"        Betonicine, stachydrine, betaine",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals, The Pharmaceutical Press, London 1996. p.284.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40924=[""].join("\n");
var outline_f39_61_40924=null;
var title_f39_61_40925="Features of hemorrhage I";
var content_f39_61_40925=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72772%7EPULM%2F51544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72772%7EPULM%2F51544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical features of major causes of immune or idiopathic alveolar hemorrhage",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disorder",
"       </td>",
"       <td class=\"subtitle1\">",
"        Extrapulmonary features",
"       </td>",
"       <td class=\"subtitle1\">",
"        Serology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Essential diagnostic criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        ABMA disease",
"       </td>",
"       <td>",
"        GN &gt;90%",
"       </td>",
"       <td rowspan=\"2\">",
"        +ABMA",
"       </td>",
"       <td>",
"        +Serum ABMA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extrarenal disease rare",
"       </td>",
"       <td>",
"        Linear IgG in glomeruli",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        SLE",
"       </td>",
"       <td>",
"        GN &gt;90%",
"       </td>",
"       <td rowspan=\"2\">",
"        +ANA",
"       </td>",
"       <td rowspan=\"2\">",
"        Clinical features, +ANA, immune complexes in glomeruli by IF, EM",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extrarenal disease common (arthritis, serositis, purpura, photosensitivity)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        WG",
"       </td>",
"       <td class=\"sublist1_start\">",
"        GN &gt;90% extrarenal disease",
"       </td>",
"       <td rowspan=\"3\">",
"        +ANCA",
"       </td>",
"       <td rowspan=\"3\">",
"        <p>",
"         Necrotizing granulomatous vasculitis in upper airway or lung biopsy",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <p>",
"         Pauci-immune necrotizing GN with extensive upper airway disease or cavitary lung nodules",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Distinctive: upper airway disease, pulmonary nodules&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nonspecific (arthritis, purpura, mononeuropathy)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Nonspecific systemic necrotizing vasculitis (microscopic polyarteritis, polyangiitis, overlap syndrome)",
"       </td>",
"       <td>",
"        GN &gt;90% extrarenal disease variably present (arthritis, purpura, mononeuropathy)",
"       </td>",
"       <td>",
"        &plusmn;ANCA (usually + if include p-ANCA)",
"       </td>",
"       <td>",
"        Necrotizing, crescentic GN (or pathologic evidence of vasculitis elsewhere) and exclude WG to extent possible",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Idiopathic pulmonary hemosiderosis",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Exclusion of all other causes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ABMA: antibasement membrane antibody; GN: glomerulonephritis; SLE: systemic lupus erythematosus; ANA: antinuclear antibody; IF: immunofluorescence; EM: electron microscopy; WG: granulomatosis with polyangiitis (Wegener's); ANCA: antineutrophil cytoplasmic antibody; p-ANCA: perinuclear ANCA; %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Leatherman JL. In: Immunologically Mediated Pulmonary Diseases, Lynch JP, DeRemee RA (Eds), JB Lippincott, Philadelphia, 1991, p.490.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pathologic features of major causes of immune or idiopathic alveolar hemorrhage",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Disorder",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Glomerular pathology",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Pulmonary pathology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Histopathology",
"       </td>",
"       <td class=\"subtitle2\">",
"        IF/EM",
"       </td>",
"       <td class=\"subtitle2\">",
"        Histopathology",
"       </td>",
"       <td class=\"subtitle2\">",
"        IF/EM",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        ABMA disease",
"       </td>",
"       <td rowspan=\"3\">",
"        Variable - segmental necrosis, crescents common",
"       </td>",
"       <td rowspan=\"3\">",
"        Linear IgG by IF",
"       </td>",
"       <td>",
"        Alveolar hemorrhage",
"       </td>",
"       <td rowspan=\"3\">",
"        Linear IgG by IF along alveolar capillary basement membrane",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic inflammation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No evidence of vasculitis",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        SLE",
"       </td>",
"       <td rowspan=\"3\">",
"        Variable - segmental necrosis, crescents in minority",
"       </td>",
"       <td rowspan=\"3\">",
"        Granular IgG by IF, electron dense deposits by EM",
"       </td>",
"       <td>",
"        Alveolar hemorrhage",
"       </td>",
"       <td rowspan=\"3\">",
"        Granular IgG by IF along alveolar capillary walls",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vasculitis of small arteries and veins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Capillaritis",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        WG",
"       </td>",
"       <td rowspan=\"2\">",
"        Segmental necrosis, crescents",
"       </td>",
"       <td rowspan=\"2\">",
"        Negative (granular IF in minority)",
"       </td>",
"       <td>",
"        Cavitary nodular parenchymal disease",
"       </td>",
"       <td rowspan=\"2\">",
"        Negative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Necrotizing vasculitis with granulomatous inflammation of the parenchyma",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Nonspecific systemic necrotizing vasculitis (microscopic polyarteritis, polyangiitis, overlap syndrome)",
"       </td>",
"       <td>",
"        Segmental necrosis, crescents",
"       </td>",
"       <td>",
"        Negative (granular IF in minority)",
"       </td>",
"       <td>",
"        Small vessel arteritis and capillaritis",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Idiopathic pulmonary hemosiderosis",
"       </td>",
"       <td rowspan=\"3\">",
"        Normal",
"       </td>",
"       <td rowspan=\"3\">",
"        Negative",
"       </td>",
"       <td>",
"        Alveolar hemorrhage",
"       </td>",
"       <td rowspan=\"3\">",
"        Negative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interstitial fibrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemosiderin-laden macrophages",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IF: immunofluorescence; EM: electron microscopy; ABMA: antibasement membrane antibody; SLE: systemic lupus erythematosus; WG: granulomatosis with polyangiitis (Wegener's); ANA: antinuclear antibody; ANCA: antineutrophil cytoplasmic antibody; p-ANCA: perinuclear ANCA; GN: glomerulonephritis.",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Leatherman JL. In: Immunologically Mediated Pulmonary Diseases, Lynch JP, DeRemee RA (Eds), JB Lippincott, Philadelphia, 1991, p.490.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40925=[""].join("\n");
var outline_f39_61_40925=null;
var title_f39_61_40926="Central dogma molecular bio";
var content_f39_61_40926=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54914&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54914&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Central dogma of molecular biology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    DNA codes for protein through the intermediary of RNA. For the longest time, it was believed that this flow was unidirectional. It is now clear that this is not entirely true. Nevertheless, this model frames the basics of our understanding of molecular biology, and while the study of genetics focuses on variation that originates in DNA, we must always be mindful that this variation has its action by eventually interfering with protein function.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40926=[""].join("\n");
var outline_f39_61_40926=null;
var title_f39_61_40927="Pes planus";
var content_f39_61_40927=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F77874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F77874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pes planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Examination for pes planus (flat feet) should be part of the evaluation of any patient with a rheumatologic complaint in the lower extremity. This condition is usually best viewed from the posterior. Eversion of the heels is also evident in this position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Sheon, RP, Moskowitz, RW, Goldberg, VM. Soft Tissue Rheumatic Pain: Recognition, Management, Prevention, 3rd ed, Williams &amp; Wilkins, Baltimore 1996.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_61_40927=[""].join("\n");
var outline_f39_61_40927=null;
